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Abstract  
 
Microfluidics has the potential to significantly change the way modern biology is 
performed, but for this potential to be realized several on-chip integration and operation 
challenges have to be addressed. Critical issues are addressed in this work by first 
demonstrating an integrated microfluidic tmRNA purification and real time nucleic acid 
sequence based amplification (NASBA) device.  The device is manufactured using soft 
lithography and a unique silica bead immobilization method for the nucleic acid micro 
purification column. The integrated device produced a pathogen-specific response in < 3 
min from the chip-purified RNA. Further enhancements in the device design and 
operation that allow the on-chip integration of mammalian cell handling and culturing 
produced a novel integrated NASBA array. This system demonstrated for the first time 
that it is possible to combine on a single micro-device cell culture and real time NASBA. 
In order to expand the cell based assay capabilities of the integrated NASBA array and 
simplify the device operation novel hydrodynamics and cell sedimentation within trench 
structures and gravity driven sequential perfusion and diffusion mechanisms were 
developed. These mechanisms were characterized and implemented within an iCell 
array device. iCell array can completely integrate cell based assays with bio-analytical 
read-out. The device is highly scalable and can enable the configurable on-chip 
integration of procedures such as adherent and non-adherent cell-culture, cell-
stimulation, cell-lysis, cell-fixing, protein-immunoassays, bright field and fluorescent 
microscopic monitoring, and real time detection of nucleic acid amplification. The device 
uses on-board gravity driven flow control which makes it simple and economical to 
operate with dilute samples (down to 5 cells per reaction), low reagent volumes (50 nL 
per reaction), highly efficient cell capture (100% capture rates) and single cell protein 
and gene expression sensitivity. The key results from this work demonstrate a novel 
technology for versatile, fully integrated microfluidic array platforms. By multiplexing this 
integrated functionality, the device can be used from routine applications in a biology 
laboratory to high content screenings. 
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Chapter 1: Introduction  
 
1.1 Motivation 
 
Living organisms are unimaginably complex creations; yet, no matter how complex, 
large or small, all living beings are assemblies of sub-units. The smallest living unit is the 
cell. Cell size can vary considerably, but most cells in mammals are in the range of tens 
of microns. To gain a better understanding of how cells function we have to be able to 
probe cells within their micron-scaled environment. Until recently, being able to access 
the micron-sized world of cells was complex and very limited. Since the development of 
the integrated circuit many micro-fabrication technologies have appeared. These 
technologies have provided the basic tools for constructing miniaturized systems that 
can operate at or below the cellular level. So far, biotechnology applications have 
benefited from using miniaturized systems [1] [2, 3]. The often-sited advantages of these 
miniaturized systems are that they allow scientists to study cells in a disaggregated form 
or at the single-cell level with a considerable reduction in reagent and sample volumes, 
increased sensitivities and higher process integration and automation. This, in turn, 
allows for parallelization and a drastic decrease in the experiment time making it feasible 
for scientists to explore the vast complexity of biological systems.   
 
However, in general, the life science community and biologists have only moderately 
made use of these emerging miniaturized tools. This is partly because existing 
miniaturized tools are simply not yet versatile and flexible enough to carry out complex 
biological protocols. The present thesis is a contribution to the field of advanced fully-
integrated micro-fluidic systems. 
 
The rest of this chapter is structured as follows: Initially, a motivation for in-vitro RNA 
analysis is presented followed by a brief overview of the principles of nucleic acid-based 
diagnostics including NAA and NA extraction and purification. Microfluidic lab-on-a-chip 
technology for bioanalysis is presented next, specifically focusing on microfluidic cell 
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capturing and culture and lab-on-a-chip devices for nucleic acid analysis such as PCR 
and NASBA devices. A further discussion of the microfluidic nucleic acid amplification 
characteristics is provided. The discussion is focused on key aspects such as 
integration, low volume and high speed processing. The chapter is finalized with a 
description of what is missing, the aims of the research and the outline of the thesis. 
1.2 Motivation for in-vitro RNA analysis  
 
As a fundamental pillar in biology, genetic information stored in DNA is translated into 
protein through messenger RNA. In the past ten to twenty years, further evidence has 
accumulated suggesting that RNA molecules perform a wider range of functions within 
the living cell machinery; these functions include among others essential catalytic roles, 
providing structural support for molecular machines and gene silencing.  
 
Generally the functions of RNA molecules in a cell are controlled through temporally and 
spatially dynamic processes of expression levels and stability. Thus determining the 
dynamics and location of RNA molecules in living cells is of substantial importance to 
molecular biology and medicine. 
 
Several tools and technologies have been created for studying intracellular RNA biology. 
These technologies are mainly based on tagged full length RNAs or probes that target 
specific RNAs. The tags used in these techniques are generally fluorescent, radioactive, 
or in some cases magnetic. Tagged full-length RNAs have been used successfully to 
monitor the localization of a specific mRNA or nuclear RNA [4], [5], [6] in living cells 
(Figure 1.1). This approach is however limited because it cannot be used to measure 
RNAs produced within the living cell. 
 
Probes that target specific RNAs enable the measurement of endogenous RNA. One 
such type of probe is the linear labelled oligonucleotides probe. Through in situ 
hybridization these probes directly label intracellular mRNA [7], but for the probes to be 
specific and function correctly several steps have to be performed. Initially cells have to 
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be fixed and permeabilized to increase the access to the target RNA and after 
hybridization unbound probes have to be washed away [8]. Signals can be further 
enhanced by designing multiple probes to target the same RNA [7]. Even though this 
type of labelling provides us with the localization information, it is quite limited. Fixing 
agents and other supporting chemicals can have considerable effect on the signal [9] 
and they can also degrade the integrity of certain intra cellular structures such as 
mitochondria. Fixing cells with cross-linking or denaturing agents and permeabilizing 
them with proteases may distort the localization of intracellular mRNA. Further more in 
situ hybridization requires that cells be fixed and thus killed so most of the dynamics on 
gene expression in the cell are lost. 
 
 
Figure 1.1. Confocal images of Oocytes cells injected fluorescent osk RNA probes 
which accumulate in the pole plasm. The injected probes were rhodamine-labelled (a, b) 
or fluorescein-labelled (c) osk RNA (3′ UTR) at the anterior. Scale bars: 100µm; 10 µm in 
images at high magnification. Reproduced from REF [4]. 
 
 
Tagged RNA-binding proteins are an alternative to oligonucleotide probes. Proteins such 
as GFP tags have been used to detect mRNA in live cells [10]. A major limitation though, 
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is that a protein has to be identified that specifically binds to the mRNA of interest. To 
resolve this challenge, a method that implants a transgene into an organism has been 
developed. The transgene generates a binding site for the phage MS2 protein [11]. 
Tagging this protein with GFP in Drosophila eggs enabled nanos mRNA to be 
specifically labelled in a living egg system. Single molecule sensitivity has also been 
demonstrated with the GFP-MS2 approach while being used to dynamically track and 
localize RNA in living cells [12]. However, generating transgenes that can fulfil the same 
functionality and behaviour as endogenous mRNA is still significantly challenging so the 
applications of this technique are limited. 
 
In order to be able to truly detect and track in-vivo endogenous mRNA, probes must 
satisfy a number of criteria:  
1. Probes should be able to convert target recognition directly into a measurable 
signal (transduction) to differentiate between background, true and false-positive 
signals.  
2. Probes should be highly sensitive for quantifying low gene expression levels. 
3. Probes should have fast kinetics for tracking changes in gene expression in real 
time. 
 
Linear labelled oligonucleotides are the simplest type of probes used in living cells for 
RNA tracking and localization studies [13] [14] [15], but these probes cause significant 
problems in distinguishing the true signal from the background. This is because they 
lack any signal transduction mechanism. To address this issue FRET based 
mechanisms have been used with linear labelled oligonucleotide probes. Signal 
transduction is done by using two linear probes labelled with a pair of donor and 
acceptor fluorophores, when the probes hybridize with their target the donor and 
acceptor fluorophores are in close proximity (within 10 nm) and a change in the emission 
spectrum occurs [15]. A limitation of this technique is that there is still a considerable 
amount of background signal and also linear probes are not sensitive to single base 
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differences (single nucleotide polymorphisms - SNPs) in the target which limits their 
application in disease studies (such as cancer detection). 
 
Hairpin nucleic acid probes try to resolve most of the deficiencies of the linear labelled 
oligonucleotide probes. One type of hairpin nucleic acid probes are the molecular 
beacons. They consists of an oligonucleotide sequence that is designed in its native 
state (in the absence of a complementary target) to form a stem-loop structure. At one 
end the molecular beacon oligonucleotide is labelled with a fluorophore and on the other 
end it is labelled with a quencher [16]. Upon hybridization with a target nucleic acid the 
molecular beacon opens and the fluorophore and quencher are physically separated, 
this allows the fluorophore to emit a fluorescence signal when excited. In ideal 
conditions, upon binding with a target the molecular beacon fluorescence intensity can 
increase over 200-fold with respect to its native state [16]. This makes the molecular 
  
                
Figure 1.2 (A) Diagram showing the concept of dual FRET molecular beacons. 
Hybridization of donor and acceptor molecular beacons to adjacent regions on the same 
mRNA target results in FRET between donor and acceptor fluorophores upon donor 
excitation. By detecting the FRET signal, fluorescence signals due to probe/target 
binding can be readily distinguished from that due to molecular beacon degradation and 
non-specific interactions. (B-C) mRNA localization in HDF cells. Fluorescence images of 
K-ras mRNA in stimulated HDF cells. Note the filamentous K-ras mRNA localization 
pattern. Adapted from REF [17]. 
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beacon a sensitive probe with a high signal-to-background ratio. Furthermore the stem-
loop structure provides a means to adjust the energy state of the molecule such that the 
stem-loop opens and hybridizes with the target when there is a perfect match. This 
enables molecular beacons to be highly specific. These transduction and high specificity 
abilities of the molecular beacon probes have made them widely used in biology and 
medicine, in applications including multiple analyte detection, real time enzymatic 
cleavage assaying, cancer cell detection, protein–DNA interactions, real time monitoring 
of PCR, gene typing and mutation detection, and mRNA detection in living cells. For 
further signal-to-background enhancement (Figure 1.2) dual molecular beacon probes 
have been used with FRET detection techniques [17].   
1.3 Principles of nucleic acid-based diagnostics  
 
In 1953, Watson and Crick [18] were able describe the structure and role of DNA 
molecules. A DNA molecule is composed of four repeating nucleotides (also known as 
nucleotide bases or simply bases): adenine, guanine, cytosine, and thymine. These 
bases form two polymeric structures or strands that coil to form a double helix 
(doublestranded DNA [dsDNA]). The attachment of the two strands is based on 
hydrogen bonds between the bases. These reversible bonds can be disrupted by heat or 
pH to form single strands of DNA (ssDNA). These single strands are relatively stable 
until the heat source or high pH is removed after which the DNA molecule reanneals (re-
forms) into the doublestranded configuration. Hybridization occurs when ssDNAs from 
different sources anneal or bind to each other. The binding process between two strands 
of DNA is quite specific; hydrogen bonds form only between complementary bases; 
adenine pairs with thymine, and cytosine pairs with guanine. This is one of the key 
aspects that allows DNA to carry information. RNA differs from DNA in that the 
nucleotide base thymine is replaced by uracil and specifically pairs with adenine. The 
hybridization strength and stability between two nucleic acid strands (DNA or RNA) 
depends on their base sequences. In a perfect base complementary match a very stable 
dsDNA is produced, however if there are one or more base mismatches there is an 
increased instability and a weaker hybridization strength between the two strands. 
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A DNA or RNA probe is a single-stranded nucleic acid that can hybridize in a specific 
way to the target nucleic acid that is of concern. Due to their stability in general DNA 
probes, are more common than RNA probes [19]. Probes are generally composed of a 
short sequence of nucleotide bases (approximately 10 - 40 bases) [20] but probes as 
long as 10,000 bases or more (molecular weight of 3,300,000) [21] [22] [23] can also be 
found. A successful probe has to be able to specifically bind to a precise site of an 
organism’s genome, since for example in a simple organism such as Escherichia coli, 
the DNA chromosome is composed of about 4.2 x 106 bp, a minimum of 20 nucleotide 
bases is usually required for statistical uniqueness [24]. Generally all the bases in a 
probe form part of the combination site, and are thus the critical factors in determining 
an assay’s specificity and sensitivity. Generally shorter probes tend to hybridize quicker 
(in the range of minutes) and are easier to prepare with synthetic methods, but are 
prone to more non-specific hybridizations and are thus limited in specificity. Furthermore 
in some cases they are more difficult to label without affecting the hybridization 
efficiency [20] [25]. On the other hand longer probes have longer reaction times, in the 
order of hours, to achieve a stable hybridization; generally they also have a lower 
stringency in the reaction conditions, meaning that they can hybridize in a greater range 
of temperatures and at lower salt concentrations. When designing a probe a few basic 
principles have to be followed, the probe must hybridize specifically to the target nucleic 
acids which should be unique and the probe must not hybridize to itself or to non-target 
nucleic acids present in the sample matrix (e.g. indigenous microbial DNA)[26]. 
 
Cellular DNA contains unique regions so targeting these regions in a nucleic-acid based 
diagnostics assay, results in high specificity. Nevertheless, RNA targets have the 
advantage of existing in much higher copy numbers compared to DNA, within a cell, 
resulting in higher assay sensitivity.  There are two main types of RNA targets, mRNA 
and rRNA. mRNA is not a widely used target because of its function as a messenger 
molecule within cells, causing its copy numbers to greatly fluctuate depending on the 
state of the cell. However in certain applications it could be advantageous to target 
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mRNA as it can allow to distinguish different cell states (e.g. between dormant and 
actively growing cells, or live and dead cells) [27]. On the other hand rRNA is one of the 
most useful probe targets, the main reasons being that it contains the 16S and 23S 
ribosomal genes, these are highly conserved genes [28] [29] used for detecting 
taxonomic groups and classifying organisms. The other relevant advantage of rRNA is it 
exists in very high copy numbers in each cell. For example each E.coli in growth phase, 
contains approximately 10,000 ribosomes and in the best case four copies of genomic 
DNA so detecting ribosomal targets rather than DNA targets increases the sensitivity by 
at least three orders of magnitude [30]. Finally whether RNA or DNA, the targeted 
sequence of nucleotides must not be present in non-target cells. 
 
Generally cellular materials of interest or infectious agents are sampled in very limited 
amounts so enrichment or culturing is required prior to detection. In some cases 
infectious agents cannot be enriched with culturing, while in general others require long 
periods of culturing time to be sufficiently enriched for detection. Furthermore extensive 
culturing has also produced highly resistant bacterial strains. So to avoid culture based 
sample enrichment other methods of enhancing the detection of nucleic acids samples 
are required.  
1.3.1 Principle of Nucleic Acid Amplification  
 
In 1983, Mullis [31] discovered a conceptually simple, single tube process for amplifying 
the number of specific nucleic acid fragments present in a sample. Later this process 
became know as PCR. PCR works by successively repeating three-steps: 
1. Dividing or denaturing dsDNA into single strands 
2. Hybridizing or annealing specific primers to the single strands of DNA. 
3. Enzymatically extending the primers to form a single strand of DNA that is 
complementary to the template strand. 
 
During the extension phase nucleotides present in the solution in excess are 
enzymatically attached to the annealed primer to form the complementary DNA strand 
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(cDNA). During the subsequent cycles, not only is the original DNA segment used as a 
template but also the newly generated cDNAs. Thus during each cycle the amount of 
specific DNA is doubled resulting in exponential growth of the number of specific DNA 
sequences. Therefore generally an amplification of 20 to 40 cycles results in a 106-fold 
increase of the sample DNA sequence [32]. 
 
 
 
Figure 1.3 Principal mechanism of PCR DNA amplification. Reproduced from REF [33]. 
 
 
The virtually unlimited amplification potential of PCR, increases diagnostic sensitivity to 
such an extent that false positives due to contamination with extraneous DNA fragments 
are a significant issue. DNA contamination can be introduced from other sources or 
carried over from previous amplifications, these problems are usually solved with careful 
laboratory procedures, such as rigid quality control of enzyme preparations and the use 
of dedicated pipettes and pre-aliquoted reagents. 
 
There are various types of PCR methods [33]; reverse transcriptase PCR (RT-PCR), 
that translates an RNA strand into DNA and amplifies it; Real time PCR in which by 
using special probes, such as molecular beacons, that fluoresce only when the correct 
hybridization occurs result in a fluorescent signal proportional to the number of target 
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sequences and thus show the amplification process in real time; and multiplex PCR that 
allows for a simultaneous amplification of different targets. 
 
Close to the same time that PCR was invented various similar isothermal amplification 
techniques were also developed, namely Nucleic acid sequence-based amplification 
(NASBA), transcription-mediated amplification (TMA) and strand displacement 
amplification (SDA) [34]. The interesting thing about these techniques is 
that they amplify DNA and RNA sequences without the need for thermal cycling though 
an initial thermal step is still required. Just like PCR, amplification with isothermal 
techniques is exponential but in the case of TMA it is faster than PCR because in each 
amplification cycle 100 to 1000 copies are created as compared with only two for PCR. 
This means TDA can produce a 10 billion-fold increase of copies within about 15–30 
min. The fact that isothermal methods such as NASBA and TMA amplify RNA strands is 
an advantage when it comes to sample cross contamination because RNA strands are 
less stable molecules which makes them less prone to contaminate other samples. 
Another interesting isothermal amplification method is the rolling circle amplification. The 
main difference and advantage of this method is that during amplification a long single-
stranded DNA of multiple repeats (as many as 1012 copies/hr) is produced. This makes 
this type of amplification very resistant to contamination and also permits to quantify the 
exact number of initial target DNAs present at the beginning of the amplification [35]. 
1.3.1.1 Principle of NASBA 
 
Nucleic acid sequence based amplification is an isothermal method for amplifying single 
stranded nucleic acid sequences such as RNA sequences (Figure 1.4.) NASBA is a 
form of transcription based amplification that relies on the replication capabilities of T7 
RNA polymerase. Transcription mediated amplification (TMA) is an almost identical 
amplification process to NASBA, the main difference between the two is that NASBA 
uses avian myeloblastosis virus reverse transcriptase (AMV-RT) while TMA uses 
Moloney murine leukemia virus reverse transcriptase (MMLV-RT). Besides performing 
reverse transcriptase MMLV-RT, also performs Rnase H type digestion, so the RnaseH 
 21
enzyme is omitted from the reaction mixture in the case of TMA [36]. The basis of this 
technique is the incorporation of a T7-promotor sequence during cDNA synthesis with 
the help of a reverse transcription reaction. This step is followed by an amplification of 
the cDNA product with T7 RNA polymerase, generating 10 to 1000 RNA copies of each 
cDNA product. The reaction follows an exponential accumulation of product because the 
newly synthesized cDNAs and RNAs serve as templates for a continuous series of 
reverse transcription and direct T7 RNA polymerase synthesis reactions. Single-
stranded RNA amplicons are produced by NASBA which can be used directly in 
subsequent rounds of amplification or probed for detection without the need for 
denaturation or strand separation. 
 
 
Figure 1.4. Nucleic Acid Sequence Based Amplification (NASBA) is an enzyme based 
technology used for the exponential amplification of nucleic acids, specially RNA, in a 
single mixture and at a constant temperature. 
 
 
Initially developed by Compton in 1991 [37], NASBA is a 41 ºC isothermal process that 
can produce in 90 min more than 109 copies of each RNA target molecule that was 
initially present in the reaction. The isothermal nature of NASBA eliminates any thermo-
cycling requirements during the procedure. Compared to other in-vitro amplification 
methods such polymerase chain reaction (PCR) [31], strand-displacement amplification 
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(SDA) [38] or rolling-circle amplification (RCA) [39]. NASBA also has the unique 
characteristic that it can, in a single assay step, amplify RNA sequences.  
 
Several nucleic acid types, including mRNA, rRNA, tmRNA, and ssDNA, as well as 
nucleic acids from virus particles, can be analysed with NASBA, enabling a range of 
diagnostics, along with gene expression and cell viability measurements [40]. In some 
cases the one step NASBA protocol can achieve levels of detection of extracted RNA a 
100 times lower [41] compared to the three step RT-PCR protocol.  Further advantages 
of NASBA over other methods such as reverse transcriptase PCR include faster 
amplification kinetics and selective amplification of RNA in a background of comparable 
DNA sequences [42] which reduces the sample purification requirements. The initial 
NASBA methods relied on liquid or gel-based probe-hybridisation for post-amplification 
detection of products. More recently, real time procedures incorporating molecular 
beacons within the amplification reaction have enabled detection in a single step.   Real 
time NASBA has become a sensitive and specific method for detection, quantification 
and differentiation of RNA and DNA targets.  
1.3.2 Principles of nucleic acid extraction 
 
To obtain successful results with in-vitro nucleic acid-based diagnostic assays the target 
nucleic acid molecules have to be accessible to the probes, primers and rest of the 
agents involved in the assay. In some cases the target nucleic acid molecules are 
shielded within cells and other complex sample matrices, moreover sample matrices can 
include assay inhibitory elements that can disrupt the successful completion of the 
diagnostic assay. Therefore in certain cases nucleic acid isolation or purification steps 
are required before the sample can be diagnosed. In certain cases when the target 
nucleic acid code is located within cells, a cell lysis or disruption procedure must be 
performed. The objective of this procedure is to release all the intracellular components 
such as DNA, RNA, proteins, etc. for the downstream analysis. The different techniques 
available for release of intracellular products include mechanical, physical, chemical, 
enzymatic and combined methods. The effectiveness of the various methods differs 
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depending on the sample matrix. In general, mechanical methods are non-specific, but 
their efficiency (between 80% and 99.9%) is higher and application broader in 
comparison to any of the other methods. For a review of the different lysis methods see 
[43]. 
 
In some cases after cell disruption, nucleic acids have to be purified from the rest of the 
lysate. This is usually required if the cell lysate contains amplification or hybridization 
inhibitors or non-specific binding promoters. Nucleic acid purification techniques are 
mainly based on two fundamental principles, differential phase solubility and specific 
solid-phase adsorption. Differential phase solubility based purification techniques 
generate conditions such that the target nucleic acid would specifically migrate to a 
separate aqueous or solid phase due to a change in the solubility of their environment. 
Then the phase containing purified nucleic acids is physically separated from the rest of 
the solution. While solid-phase adsorption techniques rely on specific adsorption 
properties that nucleic acid molecules have to certain solid phase materials. These 
methods usually generate the necessary conditions that promote the specific adsorption 
of the nucleic acid molecule to the solid phase, after which washing steps maintain the 
adsorption but remove the rest of the mixture. Finally the purified nucleic acids are 
eluted from the solid phase by removing the adsorption conditions.     
1.3.3 Nucleic acid purification 
 
The principal nucleic acid purification methods are: 
 
Nucleic Acid purification by silica adsorption 
Described by Boom et al. [44], this method uses the nucleic acids property of adsorption 
to silica matrices in the presence of chaotropic salts and alcohol [45]. The term 
"chaotropic salt" refers to the division (Hofmeister series [46, 47]) of salts into two 
subsets, chaotropic and kosmotropic salts. Chaotropic agents are salts which disrupt the 
three dimensional structure in macromolecules such as proteins, DNA, or RNA and 
denature them while kosmotropic salts have the opposite effect. According to the current 
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knowledge, guanidine thiocyanate salt is one of the most powerful chaotropes which is 
why it is commonly used in Boom based methods. Furthermore Guanidine thiocyanate is 
also characterized with having RNase-inactivating and lysing properties for viral particles 
and cellular structures [48, 49] and promotes binding of nucleic acids to silica  surfaces 
[50].  
 
The basic steps involved in this type of purification process are: 
1. First the sample is mixed with a strong Chaotropic agent and incubated with a 
solid phase silica element. 
2. NA bind to the silica surface and all other molecules remain in buffer solution. 
3. The remaining buffer is washed off the silica surface. 
4. An elution buffer removes NA from silica surfaces and NAs are collected in a 
pure solution ready for further processing. 
 
Commercially available kits commonly implement the Boom method in conjunction with 
spin columns. More recent improvements make the method more amenable to 
automation such as the use of magnetic beads that bind the nucleic acids to their 
silica surface and transfer the nucleic acids through the various steps of the extraction 
process [51] [52]. Recently also other nucleic acid binding properties or conditioning 
methods have been discovered, and based on them similar purification methods have 
been developed [53, 54].  
 
Alcohol Precipitation  
This is a differential phase solubility technique that changes the solubility properties of 
the nucleic acid containing sample, making the nucleic acids insoluble and causing them 
to precipitated into solid phase particles [55, 56] that can be separated with 
centrifugation. The technique works by adding monovalent cations (K+, Na+, NH4+) to 
the nucleic acid solution that form salts with the negatively charged nucleic acids. After 
which alcohol (ethanol or isopropanol) is added and causes the nucleic acids to 
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precipitate. Precipitations are typically performed at -20°C. However, it was found that 
ammonium acetate precipitation may be carried out at room temperature [57]. 
 
Phenol-Chloroform Extraction 
This very popular method was developed by P. Chomczynski & N. Sacchi in 1987 [58] to 
rapidly deliver high yields of RNA from multiple samples retrieving small and large, low-
abundance and high-abundance RNA isoforms. The method is based on the discovery 
that mostly total RNA free from DNA and proteins coming from cells or tissue samples 
remained soluble in the acidic aqueous upper phase after centrifugation of a mixture 
containing the sample and water-saturated phenol, chloroform and a chaotropic 
denaturing solution such as guanidinium thiocyanate [59]. After which the RNA is 
recovered from the aqueous phase by alcohol precipitation. DNA can also be recovered 
in the aqueous phase if the chaotropic denaturing agent is left out of the initial mixture. 
Thus this technique can also be used for DNA purification.  
1.4 Microfluidic lab-on-a-chip technology for bioanalysis   
 
Micro total analysis systems (µ-TAS), also known as lab-on-a-chip devices, promise to 
integrate entire analytical processes on a single microfluidic platform [60-62]. Much of 
the research effort focused during the 1990s on developing a range of analytical micro-
components, and recent activity has increasingly tackled the problem of integrating 
multiple components to achieve complex processes.  Compared to conventional macro-
scale laboratory methods, integrated µ-TAS platforms offer potential advantages of 
lower cost, higher speed, smaller sample and reagent volumes, and automation of all 
processes from sample preparation to analytical result: the “sample to answer” concept.  
For some bioanalytical measurements, however, the most important consequences of 
successfully implementing µ-TAS will be enhanced assay reproducibility and more 
quantitative results [63] relative to classical analytical procedures. 
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1.4.1 Lab-on-a-chip devices for cell capturing and culture 
 
Cell culture and cell based assays are fundamental tools in biology and the life sciences. 
Microfluidic systems provide new opportunities for the development of cell based 
assays. Some of the advantages of microfluidic cell based systems are the ability of very 
precise spatial and temporal control of cell growth and stimuli. This can be realized by 
combining surfaces that mimic complex biochemistries and geometries of the 
extracellular matrix with microfluidic channels that regulate transport of fluids and soluble 
factors. Furthermore microfluidics allows the integration of bio-analytic functionality 
together with cell handling and assaying which results in multifunctional platforms for 
basic biological insights into cells and tissues, as well as for cell-based sensors with 
biochemical, biomedical and environmental functions. These highly integrated 
microfluidic devices are especially promising for basic biomedical and pharmaceutical 
research, and can provide robust and portable point-of-care systems that would be of 
great use in clinical settings, both in the developed and the developing world. 
 
One of the basic requirements of any cell based microfluidic system is the ability to 
handle and capture cells within particular regions of a micro-system for the further 
stimulation and analysis. Several mechanical principles have been developed to capture 
and handle cells for microfluidic cell based analysis. Mechanical methods have the 
advantage of not requiring any special biochemical processing and can handle any cell 
type whether adherent or non adherent.  Mechanical methods can be classified into 
hydrodynamic, capillary and gravitational based mechanisms. 
 
Hydrodynamic mechanisms are some of the most popular methods for capturing cells. 
Di Carlo et al. [64] reported a microfluidic device composed of arrays of physical C-
shaped hydrodynamic trapping structures that can trap single cells and dynamically 
culture them (Figure 1.5). Each trapping structure is designed and dimensioned to 
capture only a single HeLa cell. While Ryley and Pereira-Smith [65] developed a 
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trapping system composed of micro-pillar chamber structures (resembling yeast jails) 
that allowed to physically capture single yeast cells and over time monitor their gene 
expression. By also using pillars and flow conditions Valero et al. [66] presented a 
silicon-glass microfluidic device capable of real time analysis of apoptotic cell death 
dynamics. In the case of Yang et al. [67] a popular dam like structure was used to 
capture cells for on-chip monitoring of cellular reactions. In this case the dam structure 
was in parallel to the fluid flow allowing the user to dock the cells of interest in precise 
locations within the device, furthermore this strategy also allowed the control of the 
number of cells retained. A common shortcoming of hydrodynamic capture mechanisms 
is that it is based on the exertion of mechanical stress on the captured or flowing cells, 
which could cause cell deformation and shear-induced changes in cell behaviour. 
Therefore to address this issue channel design and flow control must be carefully 
considered.  
 
Another astute way of trapping cells with a minimum exertion of hydrodynamic stress is 
a capillary based technique presented by Park et al. [68], where cells are captured within 
predefined micro-wells, driven by a receding meniscus formed upon natural evaporation 
of the medium solution. Cells were spontaneously inserted into the centre of micro-wells 
in order to minimize the lateral capillary force created at the bottom of the receding 
meniscus. It was demonstrated that the microwells can either be constructed with soft 
lithographic capillary moulding of UV curable PUA resin onto glass or directly with 
replica moulding of PDMS. An advantage of this technique is that capillary force is a well 
known microfluidic flow propulsion mechanism that can be naturally coupled with this 
technique to produce a pumpless loading mechanism. However a complication that 
naturally arises from using the natural evaporation of the medium solution is that cell 
viability might be compromised due to the exposure of the cells to air during the loading 
period. 
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Figure 1.5. Single cell trapping arrays. (A) A photograph of the cell trapping. The scale 
bar is 500 µm. (B) A diagram of the device and mechanism of trapping is presented. 
Trap size biases trapping to predominantly one or two cells. An inset shows the 
geometry of an individual trap. (C) A high resolution brightfield micrograph of the 
trapping array with trapped cells is shown. In most cases cells rest at the identical 
potential minimum of the trap. Reproduced from REF [64]. 
 
 
Sedimentation based on gravitational force is well known by most biologists and is the 
most direct and simple and low-expertise means for manipulating cells within solutions 
whether they be in microfluidic channels or not. The simplest way of capturing cells 
within particular regions of a micro-device whether it be for high-throughput screening or 
cell to cell signal interactions for biological research or tissue engineering is based on 
cell sedimentation and adherence to pre-coated adhesive ligands [69]. This simple 
approach generally exposes the cells to the direct flow within the micro-device and is 
thus prone to shear driven modifications in cell behaviour. To overcome this limitation, 
special microfluidic designs involving micro-wells and grooves have been developed to 
capture and localize cells exploiting gravitational force but also shielding them from 
shear stress. Khademhosseini et al. [70] introduced a simple soft lithographic technique 
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to fabricate PEG microstructures within microfluidic channels that can immobilize cells 
within specific locations despite shear flow in the channel. This technique was further 
advanced to produce multi-cell patterning with multi-cell condition testing [71]. The core 
advancement was the use of reversible sealing of a multi-channel microfluidic lid that is 
used to load each row of micro-wells with a different cell type after which the multi-
channel lid is removed and orthogonally placed over the loaded micro-wells so that each 
column of the micro-wells is subjected to a different test condition. By using open high 
density micro-well arrays Rettig and Folch [72] presented a method for generating and 
trapping high-density single cell arrays. With optimization more than 18 000 single cells 
per image (4× objective) can be analyzed and their cellular response detected. The cells 
can be adherent or non-adherent. Deutsch et al.[73] improved this concept of high-
density single cell arrays by fabricating a densely packed 2-D arrangement of hexagonal 
pico-litre wells directly in glass and placing them into a microfluidic channel that allows 
the dynamic flow medium and stimulants. Love et al. [74] astutely applied high-density 
single cell arrays made from PDMS micro-wells to the detection of hybridoma cells 
producing antigen-specific antibodies. This reduced the minimum time for a screening 
from 30 days to just 2 days. The array of micro-wells was filled with hybridoma cells and 
sealed with an antigen coated glass slide. After incubation the glass slide was detached 
and the antigen-antibody protein array analyzed through immuno-staining. This allowed 
the analysis of over 100 000 cells per assay.  
 
Although sedimentation provides a simple, low-expertise route to docking and capturing 
cells into micro wells or hollow structures, its efficiency is relatively low (between 30%-
50%) with poor reproducibility. Due to the local dispersion of cells in the solution as well 
as flow conditions cells are usually deposited non-uniformly over an area leaving many 
empty sites. An improved design or experimental set up effectively harnessing 
hydrodynamics can further enhance the efficiency and reproducibility of sedimentation 
based cell capture methods. 
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Furthermore microfluidic cell culture is very effective in terms of achieving high 
throughput parallel analysis with various culture conditions (i.e. different concentration or 
different stimuli) or various target cells. A range of concentrations can be readily 
established on the chip through the use of microfluidic gradient generators, which has 
motivated the construction of systems for the investigation of the cellular response to 
different reagent concentrations [75-79]. Multiple reagent concentrations have also been 
combined with multiple cell types on a single device to form two-dimensional cell culture 
arrays for combinatorial analysis [71, 80, 81]. Additionally 2-dimensional cell culture 
arrays with different stimuli [82] and with different reporter cells [83] have also been 
demonstrated.  
1.4.2 Lab-on-a-Chip devices for nucleic acid analysis 
 
The ideal microfluidic nucleic acid amplification device should be able to perform in small 
volumes, rapid nucleic acid amplification, with full integration of pre-amplification steps 
such as sample preparation and post amplification steps and perform all this in a highly 
parallelized platform. However, after a careful literature review, to date, such a device 
has yet to be developed.  This sub-section starts by presenting the different types of in-
vitro amplifications techniques that have been microfluidically implemented and finalizes 
by examining the key characteristics of microfluidic nucleic acid amplification.    
1.4.2.1 Microfluidic devices for nucleic acid amplification 
 
1.4.2.1.1 PCR microfluidic devices 
Conventional PCR as is done in bench-top thermo-cyclers has principally two limitations, 
the first one is that the reaction volumes require relatively large amounts of reagents 
which increases the cost per reaction and secondly there is a large thermal mass which 
limits the thermo-cycling rate and slows down the reaction. Microfluidic PCR devices 
precisely try to address these issues. Since the mid 90’s a lot of work has been 
published on the construction of microfluidic devices [84] [85] [86] [87].     
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Initially the simplest approach to microfluidic PCR [88] [89] [90] was to miniaturize the 
classical PCR thermo-cycler (Figure 1.6) and thus reduce both the reagent consumption 
and the thermal mass of the system. A further innovation to this basic approach was to 
develop a flow-based system.  
 
 
Figure 1.6 Miniaturization of a classical PCR thermo-cycler. PCR mixture is injected into 
the miniature reaction chamber and sealed with mineral oil. On-chip Pt heaters cycle the 
temperature during the amplification reaction. Reproduced from REF [90]. 
 
 
This brought a change of paradigm in PCR thermo-cycling, instead of having a static 
reaction vessel that is thermally cycled one can inject a reaction plug into a stream that 
flows across the various static temperature regimes [91] [92] [93] [94]. The flow velocity 
of the reaction plug determines the residence time at each thermal step as compared to 
conventional reactors. This resolves the thermal mass limitations and allows for PCR to 
be done in much faster rates and in a continuous reaction. The main limitations to the 
cycling rate in this type of PCR reaction are the intrinsic biochemical kinetics within the 
PCR reaction itself.    
 
Furthermore, within continuous flow PCR, reaction volumes can be miniaturized by 
encapsulating them in droplets separated by an immiscible fluid (Figure 1.7) [95] [96] 
[97] [98]. Due to the continuous flow, fast cycling and extremely low reaction volume 
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capabilities of this type of microfluidic PCR systems have a great potential for high 
throughput applications where rates of 30-50,000 reactions per day or more are feasible. 
    
 
Figure 1.7 Setup for droplet based continuous flow PCR. (A) Three-way pinch valve 2 
state loop for sequential injection with continuous flow (B) 4 step injection and droplet 
generation process using a dual diameter aspirating tip. (C) Capillary wrapped 35 times 
around a three-zone heating cylinder for PCR thermocycling and endpoint LIF detection. 
Reproduced from REF [98]. 
 
 
Recently there has also been a great interest in developing more robust and portable 
PCR systems for low resourced field point-of-care and pathogen detection applications. 
Unfortunately the microfluidic devices cited above still mostly relay on external 
mechanisms to actuate fluids and perform detections so essentially that approach 
makes them dedicated laboratory apparatuses. A promising approach to making devices 
more portable is natural convection-based flow PCR [99] [100] [101] [102] [103] [104] 
[105] [106]. The classical approach to convection-based flow PCR is the Rayleigh–
Benard (RB) convection cell (Figure 1.8) [99] [100]. The RB convection cell is 
characterized by  
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Figure 1.8. Rayleigh-Benard (RB) convection based PCR cycling cell (A) RB-PCR cell 
schematic. (B) Influence of geometry on Rayleigh-Benard convection (C) DNA 
amplification in RB-PCR cell. (i) Amplification with 0.1 U/idl Ampli-Taq Polymerase. Lane 
1, 100-bp ladder; lane 2, RB-PCR product; lane 3, PCR product generated in a thermo-
cycler. (ii) Negative control with no template. (iii) Negative control with no enzyme. (iv) 
Amplification with 0.15 U/[LL AmpliTaq Polymerase. Lane 1, 50-bp ladder; lane 2, RB-
PCR product; lane 3, thermo-cycler product. Reproduced from REF [99]. 
 
 
having two heated plates one on the top and the other on the bottom of the cell the PCR 
cocktail is contained between these two heated plates. The lower plate is held at the 
denaturation temperature (approx. 98 °C) and the upper plate held at the annealing 
temperature (approx. 61 °C). This generates a convection flow because the hot fluid on 
the bottom is less dense than that above, and rises due to buoyancy. As the less dense 
hot fluid reaches the top of the device, it cools and then begins to flow back towards the 
bottom. The suspended DNA and nucleotides are naturally flowed across the 
temperature gradient and thermo-cycled between the denaturing and annealing 
temperatures, crossing through the extension temperature during their transit. 
Advancements on natural convection PCR have demonstrated some potentially very 
simple, robust and portable systems that would be suitable for developing world 
applications, including an immersion heated system [104] and a device that runs on two 
AA batteries [106].  
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One of the key factors controlling the efficiency of natural convection PCR is the 
geometry of the microreactors. In an effort to better control the residence time of the 
DNA in each temperature zone a number of groups [102] [100] [103] [105] [106] have 
moved from simple flow cells to looped geometries. 
1.4.2.1.2 NASBA microfluidic devices 
The first successful microfluidic NASBA reactions were demonstrated by Gulliksen et al. 
(2004) [107] in 10 nL silicon-glass reaction chambers (Figure 1.9). To enable the 10 nL 
real time NASBA reaction, yeast tRNA was added to the standard reagent mixture. To 
obtain amplification in the silicon-glass micro-chambers SigmaCote surface passivation 
was required plus the addition of small quantities of carrier molecules. Due to the 
manufacturing complexity a limited number of devices were fabricated.  
 
An improvement to this initial design was shown by Gulliksen et al. (2005) [108]. The 
new design was injection moulded in COC polymer and it contained 10 parallel 80 nL 
reaction channels. Based on this design microfluidic real time NASBA was well 
characterized and shown to perform as well as conventional off chip real time NASBA. 
Off chip handling of nucleic acids especially RNA is very prone to degradation, causing 
quality and reproducibility problems. The integration of sample preparation steps with 
RNA amplification and detection all on a single microfluidic device would be very 
beneficial in decreasing the reproducibility problems. 
 
In this direction Yobas et al. [109] demonstrated all the steps required in a fully 
integrated diagnostic assay for nucleic-acid-based detection of viral particles in whole 
blood. These steps include separation of viral particles from blood cells followed by 
extraction, purification, amplification, and detection of viral nucleic acids. Unfortunately 
each step was shown to function in a separate independent microfluidic chip. In the RNA 
amplification chip, NASBA was used to amplify cDNA transcripts of the viral RNA and 
amplicons were detected on the same chip using a colorimetry assay based on DNA 
probes conjugated with horse radish peroxide (HRP).  
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Figure 1.9. The first successful microfluidic NASBA reactions were demonstrated by 
Gulliksen et al. (2004) [107] in 10nL silicon-glass reaction chambers. (A) 10 nL chamber, 
(B) Complete device. (C) Cross sectional sketch. Reproduced from REF [107]. 
 
 
Recently Furuberg et al. [110] demonstrated a semi-integrated spatially multiplexed 
NASBA based diagnostic chip. The complete diagnostic assay is done on two separate 
disposable polymer chips. The two-chip system is designed to diagnose a group of 
viruses known to cause cervical cancer. The first chip is designed to perform nucleic 
acid extraction from patient epithelial cervical cells, while the second chip performs 
NASBA based mRNA amplification and fluorescent detection. The purified sample is 
inserted into the second chip and splits into ten smaller chambers for simultaneous 
amplification and detection of ten viruses. Each chamber contains a separated set of 
lyophilized reagents that are re-hydrated (within 11 min.) before the reaction starts. A 
positive amplification of HPV type 16 viruses is shown.  
1.4.2.1.3 Other types of nucleic acid amplification devices 
Microfluidic devices based on rolling-circle amplification (RCA) have been shown 
capable of single-molecule detections (SMD). Specifically RCA provides the capability of 
transforming specific molecular recognition events at nanometre dimensions to 
micrometer-sized DNA molecules [111] which allows single-molecule enumeration. The 
specific molecular recognition event can be used to detect nucleic acids through 
hybridization reactions or low copy protein molecules through target-specific padlock 
probe ligation, followed by rolling circle amplification (RCA) [112]. RCA provides a 
means of generating a confined amplification micron-sized product that can later be 
enumerated. During RCA a circularized DNA molecule is specifically copied by a DNA 
polymerase, generating a long DNA strand composed of tandem repeats of 
complements of the circular DNA strand. The rolling circle products (RCPs) form 
individual random-coil DNA molecules and thus no physical barriers are needed to 
confine the amplification products from individual molecules in one spot. By using 
 36
fluorescent probes each random-coil DNA molecule can be labelled with hundreds of 
fluorophores making then directly visible to standard fluorescent microscopy. The RCA 
principle was first applied for biotechnological purposes by Fire [39] and Kool [113], and 
later the discrete nature of the amplification products was established by Lizardi et al. 
[114]. RPCs generated in solution can be quantified by pumping them through a 
microfluidic channel and observing the flow under a fluorescence microscope.  
 
 
Figure 1.10. Molecular recognition of DNA or protein targets through padlock probe 
ligation or proximity ligation results in the formation of a unique circular DNA molecule 
with a diameter of approximately 20 nm. The circular molecule acts as an endless 
template for a rolling-circle-replication reaction. This produces a long single-stranded 
concatemer DNA molecule complementary in sequence to the DNA circle, repeated 
approximately 1,000 times, which spontaneously collapses into a random coil of DNA. 
Fluorescent molecule–tagged probes are hybridized to the repeated sequence, resulting 
in a confined cluster of up to 1,000 fluorophores, visible in a fluorescence microscope as 
a bright object with a diameter of approximately 1 µm. Individual DNA molecules are 
detected and quantified by pumping a sample through a thermoplastic microchannel 
mounted in a standard confocal fluorescence microscope operating in line-scan mode. 
Various circles can be formed corresponding to unique analyte entities and amplified in 
the same reaction. Hybridization of detection probes of distinct colours allows 
multiplexed signal readout (as shown in the fluorescence image inset; scale bar, 20 µm). 
Reproduced from REF [116]. 
 
 
A confocal volume based technique can achieve high-precision measurements (Figure 
1.10) in the microfluidic quantification (C. V. ~3%) of RPCs [115] [116]. A further benefit 
of miniaturizing RCA was demonstrated by Hutchison et al. [117]. The principal difficulty 
with amplification of small amounts of template by RCA using φ29 DNA polymerase is 
“background” DNA synthesis that usually occurs when the target DNA is omitted, or 
present at low concentrations. By exploiting the capabilities of microfluidics the reaction 
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volume can be reduced while keeping the amount of targets fixed which in turn 
increases the template concentration, resulting in a suppression of background 
synthesis. Cloning of single circular molecules with φ29 DNA polymerase was achieved 
in 600 nL volume RCA reactions.  
 
Microfluidic based invitro transcription (IVT) of cDNA sequences from single-cell 
quantities  of mRNA immobilized on packed beads has also been demonstrated [118]. 
IVT is a linear amplification mechanism that uses T7 RNA polymerase to transcribe 
double-stranded cDNA (ds cDNA) into antisense-RNA (aRNA). It is the most commonly 
used RNA amplification method for microarray analysis because it amplifies all 
fragments at an equal rate and thus there is no significant biasing of the gene 
expression levels during the amplification [119]. 
 
1.4.2.2 Microfluidic nucleic acid amplification characteristics  
 
1.4.2.2.1 Integration 
Many argue that one of the most fundamental advantages of microfluidics is the ability to 
integrate several functions or steps on a single device. The full integration of all the 
steps required by a complete assay is key in being able realize the full potential of micro 
total analysis systems. In the case of NAA devices many research groups have 
developed devices that accommodate all or several of the necessary fluid, thermal and 
detection functions on a common device. The first attempt was to integrate PCR with a 
post amplification step such as CE for product analysis as reported by Woolley et al. in 
1996 [120]. 
 
After about ten years of research in the field of full integration and there are still very few 
devices that can demonstrate full assay capabilities, some of the best examples are 
[121] [122]. These devices integrate all the necessary steps common to diagnostic and 
pathogen detection assays and achieve sample in and answer out capabilities. Even 
though these devices demonstrate important steps in the right direction, they are still 
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quite limited in terms of their levels of detection, ability to handle complex sample 
matrixes and restricted to a defined set of protocols.    
 
Most of the work on integration has concentrated on partial component integration. This 
partial integration of procedures with NAA on a single device can be classified into main 
two fields, pre-NAA function integration and post-NAA function integration.  
 
Post-NAA function integration includes nucleic amplification analysis steps which can be 
classified as hybridization based (Microarray, Figure 1.11) [123], real time fluorescent 
based [124], electrophoresis based [61], electrochemical based [125] or immuno-
staining based [126]. Post-NAA function integration is singularly the most developed 
area within PCR integration in a single microdevice. This is most likely due to the higher 
complexities associated with sample handling during pre-NAA treatment.  
 
 
Figure 1.11. Monolithic integrated polycarbonate DNA assay device. Serpentine PCR 
channel (PCR), hybridization channel (HC), Pluronics valves (V1−V4), Pluronic traps (T), 
hydrophobic air-permeable membrane (M), PCR reagent loading holes (SL), sample 
driving syringe pump (P1), waste-withdrawing syringe pump (P2), and wash syringe 
pump (P3). Reproduced from REF [123] 
 
 
Generally the aim of integrated NAA devices is to analyze, within the confines of a 
usually portable miniaturised platform, real biological samples with complex matrices, so 
pre-NAA function integration involves sample purification and pre-concentration.  
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 Table 1.1 Microfluidic integration achievements over the last decade. 
 
Authors 
Woolley, 
A.T., et 
al. 
Waters, 
L.C., et 
al. 
Wilding, 
P., et al. 
Christel, 
L.A., et 
al. 
Yuen, 
P.K., et 
al. 
Liu, Y., 
et al. 
Lee, 
T.M. et 
al. 
Liu, 
R.H., et 
al. 
Cady, 
N.C., et 
al. 
Easley, 
C.J., et 
al. 
Wang, 
J., et al. 
Lee, J.-
G., et al.
Integration of Pre- NAA steps 
Microfluidic Filtering   ?  ?        
Immunomagnetic 
Separation        ?     
Silica based Nucleic 
Acid Purification    ?     ? ?   
Sample Desalting    ?         
Thermal Lysis  ? ?  ?   ?    ? 
Integration of Post-NAA steps 
Electrochemical Based 
Detection       ?      
Immunostaining based 
Detection           ?  
Microarray 
Hybridization 
Detection 
     ?  ?     
Real Time Fluorescent 
Detection         ?   ? 
Electrophoresis Based 
Detection ? ?        ?   
Amplification Method PCR PCR PCR PCR PCR PCR PCR PCR PCR PCR PCR PCR 
Year 1996 1998 1998 1999 2001 2002 2003 2004 2005 2006 2006 2006 
Reference [120] [61] [127] [130] [128] [123] [125] [121] [124] [122] [126] [129] 
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Sample purification is often done in two stages. First there is a cell filtration stage where 
the target cells are filtered out from the rest of the sample (examples of these are white 
blood cell separators based on microfluidic filtering [127] [128] and immunomagnetic 
bead-based separation from whole blood [121]). After the target cells are separated 
usually their DNA is extracted through lysis [129] and pre-concentration steps. The pre-
concentration is usually based on standard purification by silica adsorption [130] [124]. 
Other sample conditioning steps such as sample desalting have also been 
demonstrated [130]. Table 1.1 summarizes the microfluidic integration achievements 
over the last decade. For a comprehensive review of integration with PCR please refer 
to [131]. 
 
1.4.2.2.2 Low-volume 
With microfabricated devices comes the ability to react extremely small volumes of 
solution. The smallest nucleic acid amplification (NAA) reaction volume reported to date 
is found in the work by Beer et al. [132]. Their device is based on a shearing T-junction 
made in a silicon substrate to generate a stream of aqueous monodisperse picolitre 
droplets in an oil-phase carrier (Figure 1.12). Once the droplets were generated, they 
were statically kept inside the microfluidic channel and thermally cycled on a peltier 
based system and fluorescently interrogated during each thermal-cycle.  With this 
system, a 10 pL droplet, encapsulating less than one copy of viral genomic DNA 
(verified through Poisson statistics), showed real time PCR amplification curves with a 
cycle positive threshold of ~18. This is approximately 20 cycles earlier than what is 
common in conventional instruments. Since the entire micro-device is heated the 
thermal cycling rates are quite slow, requiring 108 min. for 40 amplification cycles.    
 
Another very low volume NAA device was demonstrated by Nagai et al. [133] who 
fabricated an array of 86 pL microchambers on silicon substrates with silicon oxide on 
the inner walls. Smaller chamber size was explored but no detectable amplification was 
observed. The device did not exploit the small volumes for a fast thermal cycling. 
Instead the complete device was placed onto a conventional thermo-cycler requiring 2 
hrs to complete 40 cycles.  PCR end product was fluorescently detected with real time 
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Taqman probe with a fluorophore and a quencher. The amplification was observed in 
real time by a CCD camera through a microscope.      
 
In a more operational attempt Liu et al. [134] reported the use of hydraulic valves and 
pneumatic pumps to perform PCR in 3 nL reaction volumes. Even though this system 
has a considerably higher reaction volume it has the advantage that it can very 
efficiently load 400 distinct parallel reaction chambers. Through a valve multiplexing 
system the device can load an N x N matrix of reaction centres with just 2N + 1 pipetting 
steps compared to the conventional 3N2 steps. As in the previous cases this work does 
not focus on the thermal cycling speed so the entire device was placed on a 
conventional thermo-cycler tacking 1 hr to complete the amplification of a 294-bp  
fragment of the human β-actin cDNA fragment. 
 
 
 
Figure 1.12. Images of the low volume PCR chip showing (a) the overall channel and 
flow configuration, (b) droplet generation at the T-junction, and (c) monodisperse 
droplets in the downstream channel. Real time PCR data from picolitre droplets at an 
estimated (d) 0.06 copies of genomic DNA per singlet droplet. Droplets were identified 
from the bright-field image and then monitored at each cycle to generate real time 
fluorescence curves. Adapted from REF [132]. 
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The lowest volume non-PCR NAA device was reported by Gulliksen et al. (2004) [107] 
with a  10 nL real time NASBA reaction in silicon-glass reaction chamber. Since NASBA 
in an isothermal reaction no cycling is required and the whole chip was incubated at  
41 °C. The real time NASBA reaction was shown to generate a positive signal 
distinguishable over the background noise in approximately 20 mins. 
 
Small volume NAA is advantageous in reducing the cost of reagents used for the 
amplification. In case of nucleic acid amplification reactions that also require thermal 
cycling such as PCR the reduced volume should also allow for more rapid thermo-
cycling. However, as described previously, the use of small-volume thermal cycling 
chambers does not necessarily coincide with reduced amplification times if the mode of 
heating does not exploit the advantages of low-volume design. This is generally the 
case when the entire device is thermo-cycled. In order to avoid the complications and 
thermal optimizations required in PCR based reactions other isothermal forms of nucleic 
acid amplification may be used. Furthermore these forms of amplification can be 
biochemically optimized to produce extremely fast amplifications. For example in 
NASBA each cycle produces 10-1000 copies of the template compared to just a 
doubling in PCR reactions. 
 
1.4.2.2.3 High-speed 
Commonly in case the of NAA reaction that require thermal cycling such as PCR 
reducing  the  thermal mass  of  the  system  can  increase  the  heating  and  cooling 
rates during temperature cycling. This has the advantage that it can speed up the 
amplification reaction, this is important in applications where high throughput processing 
is critical.  The fastest reported NAA reactions to date are performed with a flow-through 
PCR device where the only thermal mass was the solution and not the micro-device. 
Hashimoto et al. [135] is one such case with the flow-through device, they achieved  
amplification of a 500-bp region of λ-phage DNA in only 1.7 min and a  997-bp  fragment  
took 3.2  min. In case of flow though devices, since the thermal mass is so small, the 
factor that limits the speed of the reaction is the kinetic limit of nucleotide incorporation 
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by Taq polymerase and not the thermal cycling. This was the case with Hashimoto et al. 
[135] where the temperature transition is faster than the kinetic limit of nucleotide 
incorporation thus  the  system  is  limited  only  by  the  properties  of  the  enzyme. This 
means that as one increases the thermal cycling speed to over a certain threshold the 
amplification efficiency is reduced This results in very poor levels of detection 
(Hashimoto et al. reported an LOD of 1 x 107 copies). Another flow-through PCR device 
capable of either PCR or reverse-transcriptase  PCR  (RT-PCR)  developed  by Obeid  
et  al. [136] improved the LOD to 6.25  x  106 copies  within 6 min. The PCR and RT-
PCR reactions were performed with volumes ranging from 10 µL to 700 nL. 
 
Another way of increasing the thermo-cycling speed but also maintaining a low reaction 
volume was pioneered by Landers and co-workers [89] that use infrared-mediated 
heating for performing the thermal cycling. Infrared-mediated heating has the advantage 
that it can focus all the thermal heating only on the solution in the PCR chamber. This is 
further optimized by completely etching away as much of the glass near the PCR reactor 
and so minimize heating of the surrounding area. In demonstrations IR-mediated  PCR  
has  been performed  in  just  4 min,  resulting  in  one  of  the  fastest  cycling  times  
using  a non-flow-through  system.   However, the use of IR-mediated heating requires 
an IR-source, and it is not easily integrated into a portable system.    
 
An elegant system that can combine both high speed cycling and very low reaction 
volumes was recently demonstrated by Rothberg et al. [137]. Roughly millions of real 
time PCR reactions were done in uniform, monodisperse droplets of 65 pL. The droplets 
were generated via flow-focusing where the PCR mix was infused with two 
perpendicular channels flowing immiscible oil. Thermal cycling was achieved by flowing 
the droplets though distinct thermal zones resulting in a rapid (55-s cycles) and efficient 
PCR amplification. An 18 cycle amplification time would take 16.5 min. The droplets 
were shown to be able to perform single molecule PCR. The device was used for 
limiting dilution PCR (also known as digital PCR) very useful in high precision detection 
and quantification of the number of initial templates.  
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1.4.3 What is missing and aim of this research 
 
Recent advances in NAA micro-devices most notably in PCR based-devices have 
produced high-throughput, sensitive, and rapid systems. Most of these systems 
effectively integrate amplification and post-amplification functionality. The few systems 
that do integrate pre-amplification functionality are exclusively designed for diagnostics 
and pathogen identification. Even though nucleic acid amplification is a ubiquitous 
technique used throughout the life sciences and has revolutionized the way information 
is extracted from biological samples, it has yet to be developed and integrated into 
microfluidic systems for total cell based analysis. Furthermore since the invention of 
PCR other amplification techniques have also been developed, NASBA is one such 
technique that poses advantages over PCR such as isothermal amplification, lower non-
specific detection and direct amplification of RNA (critical in gene expression analysis, 
bacterial and viral diagnostics, cell viability analysis, etc.). Yet microfluidic systems that 
exploit the advantages of NASBA have been very limited, and there have been no 
previous reports or demonstrations of integrated microfluidic NASBA devices with pre-
amplification functionality. Moreover despite all the advantages of microfluidics current 
integrated and multiplexed systems require expensive and complex fluidic setups to be 
operated, this has contributed to the slow up-take, deployment and use of the 
microfluidic tools and systems by the general community. There is an evident lack of 
simple and robust microfluidic systems that can be easily adopted and used by a non-
specialized community of microfluidic users.      
 
Microfluidics has demonstrated important advantages over its conventional counterpart 
technology. These often cited advantages are decreased reagent and sample 
consumption and waste, faster analyses, more controllable process parameters and 
higher parallelism. To date, however, most of the microsystems developed do not take 
advantage of the potential of a fully integrated functionality offered by the miniaturized 
nature of the systems. The goal of the work presented in this thesis is to develop the 
necessary components and integration mechanisms that can enable high-throughput 
and fully-integrated systems with sample or experiment-in and answer-out capabilities.   
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1.5 Outline of the thesis 
 
Chapter 2 outlines the principal theoretical models and calculations related to the novel 
microfluidic technologies and techniques propose in this thesis. Firstly the behaviour of 
flow in microfluidic devices is briefly discussed. This is based on the Navier-Stokes 
model in the region of laminar flow and low Reynolds numbers (Re<10). Secondly the 
convection-diffusion equation is presented as a dynamic model for species mixing in a 
flow field. Thirdly a basic cell sedimentation model is described for the calculation of the 
cell trajectories and capture efficiencies. Finally a hydrostatic pressure model is 
presented as a means for generating flow within microfluidic devices. 
 
Chapter 3 presents all the experimental details associated with the results shown in the 
following chapters. The chapter is divided into three main sections; each section focuses 
on one of the principal micro-device designs. The three designs are the RNA Extraction 
& Real Time NASBA device, iNASBA array device and the iCell array device. Each 
section shows the device design, device operation, all the fabrication procedures 
required for implementation and the materials and methods associated with the 
characterization of the device. 
 
Chapter 4 presents the characterization results of the RNA Extraction & Real Time 
NASBA device incorporating real time detection. The real time amplification and 
detection step produces a pathogen-specific response in less than 3 min from the chip-
purified RNA of 100 lysed bacteria. On-chip RNA purification uses a novel silica bead 
immobilization method. On-chip amplification uses custom-designed high-selectivity 
primers and real time detection uses molecular beacon fluorescent probe technology; 
both are integrated on-chip with NASBA.   
 
Chapter 5 presents the characterization results of the iNASBA array. The iNASBA array 
for the first time demonstrates that microfluidic dynamic cell culture, cell stimulation, cell 
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labelling, lysis, and real time NASBA based RNA analysis can de done a on a single 
chip. 
 
Chapter 6 presents the characterization results of the novel micro-fluidic technology, 
iCell array that can perform completely integrated cell based assays with bio-analytical 
read-out protocols such as immuno-fluorescent imaging or real time NASBA based 
nucleic acid amplification. The iCell array permits the parallel and configurable on-chip 
integration of complex procedures such as adherent and non adherent cell culture, cell 
stimulation, cell lysis, cell fixing, protein immunoassays, bright field and fluorescent 
microscopic monitoring, and real time detection of nucleic acid amplification. With 
onboard gravity driven flow control the device is simple and economical to operate, very 
low reagent volumes (50 nL per reaction or less) are required for the device to function, 
and it does not use any external macro-scale power sources. This enables the iCell 
array to be directly used with existing laboratory infrastructure such as multichannel 
pipettes and/or robot fluid handling systems, incubation or environmental control 
chambers and microscope systems. iCell array can process up to 512, 10 nL reactions 
in a single chip and up to 64 different user selected integrated assays can be done 
simultaneously. 
 
Finally, chapter  7 discusses  the  prospects  and  possible  future  applications  of  the  
devices and technologies developed in this thesis and concludes with a summary of the 
research results.    
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Chapter 2: Theory  
 
This chapter outlines the principal theoretical models and calculations related to the 
novel microfluidic technologies and techniques proposed in this thesis. First, the 
behaviour of flow in microfluidic devices is briefly discussed. This is based on the 
Navier-Stokes model in the region of laminar flow and low Reynolds numbers (Re<10). 
Second, the convection-diffusion equation is presented as a dynamic model for species 
mixing in a flow field. Third, a basic cell sedimentation model is described for the 
calculation of the cell trajectories and capture efficiencies. Finally, a hydrostatic pressure 
model is presented as a means for generating flow within microfluidic devices. 
2.1 Navier-Stokes model 
As opposed to Lagrangian Modelling where dynamics is expressed in terms of a set of 
point vectors {ri} that describe the position in time of every particle in the system 
Eulerian Modelling statistically summarizes the molecular level details in statistical 
quantities like temperature and pressure as function in space and time. This means that 
mechanical quantities such as mass mi, velocity vi and force Fi become a mass 
distribution m(r), a velocity field v(r) and force field F(r). This greatly simplifies fluid 
analysis where modelling problems generally have to analyze the dynamics of more 
than 1023 particles (1 mole).  
 
The Navier–Stokes equations for modelling fluid flow, in their general form are the 
expression of Newton's second law (the conservation of momentum) in a continuum 
form and written for an arbitrary control volume. This yields; 
 
FSv +∇−⋅∇= p
Dt
Dρ    (2.1) 
using the material derivative and v to represent flow velocity field the left side of the 
equation describes acceleration multiplied by ρ the fluid density, while the right side of 
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the equation describes the summation of body forces F (such as gravity) and divergence 
(∇ the del operator) of stress (p pressure and S is the stress tensor). If the material 
derivative is extended the Navier-Stokes equations assume the form:  
 
FSvvv +∇−⋅∇=⎟⎠
⎞⎜⎝
⎛ ∇⋅+∂
∂ p
t
ρ   (2.2) 
 
2.1.1 Incompressible flow of Newtonian fluids 
 
If the fluid is assumed incompressible ρ(r, t) = const. then mass continuity can be 
expressed as:  
0v =⋅∇      (2.3) 
 
Using these relations the Navier-Stokes equations can be rewritten as: 
 
Fvvvv +∇−∇=⎟⎠
⎞⎜⎝
⎛ ∇⋅+∂
∂ p
t
ηρ   (2.4) 
 
The assumption of incompressibility means that effects such as shock or sound waves 
are disregarded from the model and are assumed to be non-important. Even though 
incompressibility is assumed the equations can be applied to liquids with small 
compressibilities (less than 10−9 Pa−1) without significant error. 
2.2 Laminar Flow Simplification 
 
In the case of laminar flow the (2.4) can be further simplified. The key factors are that 
inertial effects are not present during laminar flow and the body forces such as gravity or 
centrifugal can also be neglected. Simplifying the convective (inertial) term (v·∇)v = 0 
and the body force term F from (2.4) the so called Stokes equation is obtained: 
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p
t
∇−∇=∂
∂ vv 2ηρ     (2.5 ) 
 
The key feature of this equation are that velocity field v is always linear and it expresses 
that the pressure force -∇p is completely spent on overcoming the viscous losses 
expressed by the term η∇2v. One way of further characterizing the type of flow is the 
so called Raynolds number. 
2.2.1 Reynolds Number 
 
Conceptually the Reynolds number (Re) is a dimensionless indicator that summarizes 
the dynamics of the Navier-Stokes momentum equation (2.4). The emergence of this 
indicator is apparent if the equation (2.4) is made independent of physical dimensions. 
This is done by applying the following substitutions to eq 2.4: 
2v
,
v
,v,
ρ
ppp
l
tt
l
xx −→→→→ vv   (2.6) 
this results in: 
Fvvvv 2
2
vv
lp
lρt
+∇−∇=∇⋅+∂
∂ η
   (2.7) 
In the cases where the bodily forces such as gravity or centrifugal are not relevant then 
the F term can be discarded and simplified it to: 
p
lρt
∇−∇=∇⋅+∂
∂ vvvv 2
v
η
   (2.8) 
From 2.8 it can be seen that the dimensionless term lρv
η
 completely characterise the 
dynamics of the equation. This is why the Reynolds number is defined as: 
Re
1
v
=
lρ
η
    ⇒ forces viscous
forces inertialvRe == η
lρ
   (2.9) 
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Based on this concept the Reynolds number can be defined for a number of different 
situations and the definition should generally include the density and viscosity properties 
of the fluid, its characteristic velocity and a characteristic dimension or length of the 
boundary conditions. The term characteristic refers to a velocity and a length that is 
representative of the inertial forces in the system such as the dynamic pressure and the 
viscous forces due to the viscous stress. General definitions of characteristic dimensions 
include for example the diameter for spheres, circles or pipes. For non-spherical shapes 
an equivalent diameter is usually defined as a ratio between the cross sectional area 
and the perimeter. 
2.2.2 Reynolds Number Values 
 
Values of the Re are commonly between 0.001 and 100,000 [1]. It is generally cited that 
systems where the Re number is above 2300 [1] the flow is a fully developed and 
turbulent while Re numbers below this transition threshold are completely laminar. 
Generally microfluidic channels with cross sectional areas of 100µm x 100µm and 
lengths in the order centimetres supporting flow rates of micro-litres per minute have Re 
numbers in the range of 10 or less. This is much lower then the transition threshold of 
2300. These low Reynolds number flows guarantee that for example in straight channel, 
every fluid particle moves with uniform velocity along straight streamlines or laminas.  
 
2.2.3 Numerical Solution 
 
Only few analytical solutions exist for the Navier-Stokes equations, the two main ones 
are the Hagen-Poiseuille flow [2] through a circular cross sectioned tube and Couette 
fluid [2] flow between two infinite parallel flat plates driven by the motion of one or more 
of the plates. However in most particle problems these simplified solutions are not 
sufficient to analyze and describe fluid dynamics in complex geometries, multi-phase 
fluid interactions, fixed or flexible solid boundary structures and interactions with 
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electrical, thermal, acoustic or optical phenomenon. To address these issues 
computational fluid dynamics (CFD) can be used to numerically solve these highly 
coupled and complex multi-physics problems [3]. 
2.3 Convection Diffusion 
Another critical aspect of any microfluidic device is the phenomenon of chemical and 
biochemical species transport within the microfluidic system. Species transport can be 
modelled based two phenomenon convection and diffusion. The relation between these 
phenomenon and the fluid velocity field v and the concentration profile is given by the 
convection–diffusion equation: 
 
)()( cDc
t
c ∇⋅∇+⋅−∇=∂
∂ v    (2.10) 
 
This equation is composed of two terms. The first term is the convective term that 
expresses the effect of the inhomogeneous flow field on the concentration profile 
represented by the scalar field c. More precisely the advection term ∇·v is the 
calculation of the transport of a scalar (c) by vector field (v). The second term of (2.10) 
models the diffusive transport due to the formation of a concentration gradient ∇c as 
stated in Fick’s law [4]. The convection-diffusion equation can also be viewed as an 
extension of the continuity equation (2.3) such that the principal of the conservation of 
mass is satisfied in conjunction with diffusive and advective transport. 
2.3.1 Indicator for Mass Transport the Péclet Number  
 
The Péclet number (Pe) is defined as the quotient between advective and diffusive 
mass transport. 
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 transportmass diffusive
 transportmass advectivePe ==
D
vl
  (2.11) 
 
where l represents the characteristic length, v the fluid velocity and D the diffusion 
coefficient. For diffusion coefficients ranging from 10-5 m2s-1 to 10-11 m2s-1 the Péclet 
number in a typical microfluidic device is usually 100 < Pe < 100,000 [5] which means 
that a advective transport of species dominates within microfluidic systems. That is why 
there has been a great effort in the community to develop strategies for purposefully 
enhancing species mixing within microfluidic systems.  
 
2.4 Cell flow and sedimentation model  
 
In order to model cell flow and sedimentation within fluid velocity field we have to 
account for the forces that are exerted onto a particle suspended within a fluid. These 
forces a depicted within Figure 2.1. The forces are the buoyancy-corrected gravitational 
sedimentation force Fgb and the fluid drag force Fd.  
g∆mp=gbF     (2.12) 
 
where ∆mp represents the difference in the masses of the particle and the displaced fluid 
volume. Thus particle trajectories can be calculated by solving the force balance 
equation for any given particle: 
gbd F
rrFr += ),,(2
2
dt
dt
dt
dmp    (2:13) 
 
The fluid drag force Fd ∝ v is modelled by the Khan and Richardson force [6] which is 
an empirical estimation of the fluid drag force on spherical particles with radius that is 
valid for a wide range of Reynolds numbers, (including Re<1). 
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 (2.14) 
 
Where the suspended spherical particle has a mass mp and a radius rp immersed in a 
fluid with a density ρ, dynamic viscosity η and velocity field v. 
 
Figure 2.1. Particle suspended in a liquid volume under the impact of a gravity field and 
a fluid flow field. The motion of the particle follows the buoyancy corrected gravitation 
force Fgb which accounts for the mass difference ∆m between the particle and the 
displaced liquid volume in combination with the fluid drag force Fd. 
 
 
 
2.5 Hydrostatic pressure model  
 
This type of pressure arises from to the weight of a fluid column and can be described 
through the Bernoulli equation. The Bernoulli equation can be directly derived from the 
Navier-Stokes model by applying the following restrictions: 
1. The fluid is assumed incompressible:   .),( consttr =ρ   (2.15) 
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 2. The velocity field can be described as the gradient of a velocity field potential:  
0=×∇⇒−∇= vv U        (2.16) 
3. The flow is assumed to be inviscid, that is to say the fluid has zero viscosity:  
0=η          (2.17) 
4. The body forces must be conservative and thus be generated from the field potential: 
Φ−∇=F          (2.18) 
If these restrictions are applied to eq.(2.4) and Φ is considered to be the gravitational 
potential we obtain the following: 
pUUU
t
∇+Φ∇+∇∇⋅∇+−∇∂
∂= ρ
1)(0    (2.19) 
⎥⎦
⎤⎢⎣
⎡ +Φ++∂
∂−∇= ρ
p
t
U
2
0
2v
    (2.20) 
.v
2
1 2 constpρghρ =++    (2.21) 
Using Bernoulli’s equation to model a microfluidic device coupled to a macro scale 
column of fluid as shown in Figure 2.2. The dynamic pressure component of the 
Bernoulli equation can be disregarded since the flow rates generated within the reservoir 
outlet (Figure 2.2 radius b) is 2 orders of magnitude smaller than the flow rate through 
the device making the dynamic pressure term 4 orders of magnitude smaller than the 
reservoir hydrostatic pressure. This means that the pressure generated at the inlet of the 
microfluidic device is mostly hydrostatic pressure directly proportional to the fluid column 
height. 
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Figure 2.2. Microfluidic device coupled to a macro scale column of fluid with a density ρ. 
The maximum fluid column height is given by the container (eg. 1 mL Eppendorf pipette 
tip) height ht. while the column width can be represented by the container inlet and outlet 
inner radius a, b respectively. ht represents the fluid column height at any given point in 
time. The orders of magnitude of the variable dimensions are represented as well as the 
direction of the gravitational acceleration. 
 
Furthermore the flow through the microfluidic system coupled to hydrostatic fluid column 
can be modelled as Puisille flow resulting in a linear relationship between the pressure 
gradient and the flow velocity through the microfluidic system. This linear relation is 
described by the hydraulic resistance of the device. 
QRP h ⋅=∆     (2.22) 
In case of a conical fluid column as shown in Figure 2.2 the column height as function of 
time can be estimated by applying the following differential model that relates the height 
variation with time: 
Q
dt
dV −=      (2.23) 
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ftf
hbabRhbaR
ρghh
dt
dh
)(3)(
3
−+−= ππ   (2.24) 
 
2.6 Summary 
 
In this chapter, models for microfluidic operation were introduced: The Navier-Stokes 
equation and its simplification for microfluidic systems, which is directly applicable to 
microfluidic cell handling, the convection and diffusion model for species transport and 
distribution which is directly applicable to cell based assays and enzymatic reactions 
within microfluidic systems, the cell sedimentation model which is the key to microfluidic 
cell capture and finally a hydrostatic pressure model which is directly applicable to 
gravity drive flow within a microfluidic system.  
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Chapter 3: Experimental Details 
 
 
This chapter presents all the experimental details associated with the results shown in 
the following chapters. The chapter is divided into three main sections; each section 
focuses on one of the principal micro-device designs. The three designs are the RNA 
Extraction & Real Time NASBA device, the iNASBA array device and the iCell array 
device. Each section shows the device design, device operation, all the fabrication 
procedures required for implementation and the materials and methods associated with 
the characterization of the device.    
3.1 RNA Extraction & Real Time NASBA device 
 
In this sub section, a monolithic integration of a microfluidic sample-to-answer tmRNA 
analysis system that includes RNA capture and purification, NASBA, and real time 
detection is presented.  A novel clog-free bead immobilisation method is used to 
construct the RNA capture and purification module.  The device design also allows for 
future integration of cell lysis and automated fluid-control functions. 
 
 
Figure 3.1 Integrated microfluidic RNA purification chamber and real time NASBA 
device. (A) Photograph of the device.  The microfluidic architecture is mirrored to allow 
for 2 separate reactions with the same reagents, but different samples, to incorporate 
controls.  (B) Single device architecture showing the distinct functional microfluidic 
modules: RNA purification chamber (RPC) and real time NASBA chamber.  The 
remaining channels and chambers have been included for future integration of on-chip 
lysis.  All channels and chambers are 80 µm high.  Scale bar is 1 mm. Reproduced from 
REF [1]. 
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3.1.1 Device Design  
 
The integrated microfluidic NASBA chip, Figure 3.1 (for detailed design schematic 
please see the attached file: “RNA Extraction & Real Time NASBA device.dwg”), is 
based on microchannels and microchambers, with distinct functional domains: a silica 
bead-bed RNA purification chamber (RPC, volume 0.25 µL), and a NASBA chamber 
(NC, volume 2 µL).  The remaining channels and chambers have been implemented for 
the future integration of on-chip chemical lysis.  The height of the microchannels and 
microchambers, 80 µm, was selected because it is easily achievable with SU-8 2100 
photoresist.  The RNA purification chamber enables capture of RNA present in the 
sample by selective adsorption in silica, followed by removal of the remaining crude cell 
lysate, which includes NASBA inhibitors, by washing. 
 
Detection of amplified tmRNA target from NASBA occurs in real time via molecular 
beacons whose fluorescence is unquenched when hybridised to complementary RNA 
amplicons.  The device is characterized using a fluorescence microscope to measure 
the change in fluorescence from the NASBA chamber as a function of time.  The device 
is mirrored (Figure 3.1A) to allow for 2 separate reactions with the same reagents but 
different samples, nominally to implement control reactions.  The relatively large number 
of inlets (7) and outlets (4) is a consequence of this device being designed as a 
subcomponent of a larger system that is being developed, where a number of the fluidic 
I/O connections will be replaced with microchannel connections to other components 
and/or on-chip reagent or waste reservoirs. 
3.1.2 Device Microfabrication  
 
PDMS is widely utilized for microfluidic devices due to the ease of fabricating relatively 
complex structures [2], its general biocompatibility, and the ease of attaching (sealing) it 
to glass, silicon wafers, or a second PDMS structure.  Microfluidic channels were 
fabricated using standard soft lithography replica moulding techniques [3].  A mould was 
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created through a single-layer process using negative photoresist, SU8-2100 
(Microchem, U.S.A.), which was spun onto a clean silicon wafer using a spinner (P6700 
Specialty Coating Systems, Inc., U.S.A.).  The resist (5 mL) was spread onto the wafer 
at 500 rpm for 10 s, and the rotation rate was then ramped at an acceleration of 300 
rpm/s to 2,500 rpm, at which rate the sample was spun for 30 s to form an 80 µm layer.  
The wafer was then soft baked at 65 ºC for 5 min and 95 ºC for 30 min, then UV-
exposed for 10 s at 9.5 mW/cm2 using a Karl-Süss KSM MJB-55W mask aligner.  The 
wafer was post-exposure baked for 5 min at 65 ºC and 12 min at 95 ºC, allowed to cool 
to room temperature, developed in Microposit EC Solvent (Chestech Ltd., UK) developer 
for 4 min, and finally blown dry with nitrogen.  PDMS (Sylgard 184, Dow Corning) was 
prepared according to the instructions of the manufacturer, degassed in a vacuum 
chamber for 30 min, then poured on the SU8 mould and cured in a 60 ºC oven for 10 h.  
The PDMS was then carefully peeled off the mould.  Fluid inlets and outlets were 
punched with a 1 mm outer diameter flat-tip needle for tube connections.  Both a 25 x 50 
x 0.4 mm glass cover slide (VWR International Inc., U.S.A.) and the PDMS structures 
were treated with UV ozone (PSD-UV, Novascan Technologies, Inc., Iowa, U.S.A.) for 
10 min before bonding for 10 h at 90 ºC.   
3.1.3 Silica Bead Loading and Immobilization  
 
Beads for RNA purification were immobilized within the RPC by loading 3 µL of a 68% 
(bead: deionised H2O volume) solution of 10-µm plain silica beads (PSi-10.0, G. Kisker 
Gbr., Germany) into the input port (IP) (Figure 3.2 A), with all other ports on the chip 
sealed except for the waste output (WO).  The bead solution was left to dry at room 
temperature for 3 hr, which packs the beads into the extraction chamber.  After the 
beads dried in place, they were immobilised via bonding to the PDMS walls of the 
extraction chamber using UV ozone treatment: the chip was treated with ozone for 10 
min to activate the PDMS, then left to bond overnight at room temperature (Figure 3.2 
B).  Finally, a bead-washing step with deionised H2O (dH2O) was performed (Figure 3.2 
C) to remove unbound beads and leave a layer of silica beads bonded to the walls of the 
RPC. To simplify device fabrication and the on-chip operation, beads for RNA 
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purification were immobilised within the RNA purification chamber (RPC). Beads can be 
positioned precisely into the RPC by loading a limited volume of 3 µL of a 68% (bead: 
deionised H2O volume) solution of 10-µm plain silica beads (PSi-10.0, G. Kisker Gbr., 
Germany) into the input port (IP), with all other ports on the chip sealed except for the 
waste output (WO). This dense solution of beads is left to dry at room temperature for 3 
hr. This packs the dry silica beads into the extraction chamber.   
 
 
Figure 3.2 Method for silica bead immobilisation on PDMS surface.  (A) Before loading 
the beads, all ports are sealed except for the Input and Waste Output. (B) 3 µL of plain 
silica bead solution flows into the input, left to dry, and exposed to UV-ozone for 
bonding.  (C) Unbound beads are washed away with dH2O, leaving a (D) layer of silica 
beads bonded to the walls of the RPC (see Supporting Information). (E-F) Bright-field 
micrographs of the immobilised 10 µm silica beads on the PDMS walls of the RNA 
purification chamber. Reproduced from REF [1]. 
 
 
After the beads dried in place, similar to conventional PDMS glass bonding, the silica 
beads are immobilised via bonding to the PDMS walls of the extraction chamber by 
 70
using UV ozone treatment.  The chip with the packed dried silica beads was treated with 
ozone for 10 min to activate the PDMS, then left to bond overnight at room temperature.  
Finally, a bead-washing step with deionised H2O (dH2O) is performed to remove 
unbound beads and leave a layer of silica beads bonded to the PDMS walls of the RPC.   
 
To demonstrate that the beads were immobilized on the surface of the PDMS within the 
RPC chamber a new PDMS-PDMS chip was fabricated instead of the reported PDMS-
glass.  The immobilization strategy followed was exactly the same except that 10 µm 
green-fluorescent silica beads were used.  The microfluidic chip was then cut across the 
RPC chamber to generate a cross-sectional view of the bonded bead and imaged with a 
fluorescent microscope, as shown in Figure 3.2.1 
 
 
Figure 3.2.1 Fluorescent image of a cross section of the RPC chamber showing a layer 
of immobilized green fluorescent silica beads on the PDMS walls. Please note that in 
this case the entire device is made of PDMS, for ease of cutting the bottom glass cover 
was replaced with a flat PDMS layer. Scale bar 30 µm. Reproduced from REF [1]. 
 
 
3.1.4 E.Coli Culture and Lysis 
 
The E. coli strain XL-1 blue was cultured overnight at 37 °C with 250 rpm shaking 
(Gallenkamp orbital shaker, AGB Scientific Ltd., Ireland) in LB medium (Lysogeny broth, 
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also known as Luria broth) containing Tryptone (10 g/L, Lab M Ltd., UK), yeast extract (5 
g/L, Lab M Ltd., UK) and NaCl (10 g/L, Sigma-Aldrich Ireland Ltd., Ireland) made in-
house and autoclaved at 121 °C for 20 min.  The cell density was measured as optical 
density at 600 nm (OD600) on a spectrophotometer (UV-160A, Shimadzu).  The number 
of cells per mL was calculated from a standard curve based on plate counts.   
 
Cell lysis was performed off chip using MicroLYSIS PLUS buffer (Microzone Ltd., UK) 
according to the manufacturer’s recommendations.  An overnight culture of E. coli 
(OD600 of 1.36) with a cell density of 3.4 x 108 colony forming units (CFU)/mL (based on 
plate counts) was centrifuged at 10,000 rpm for 5 min, producing a pellet volume of 5 µL, 
and mixed with 40 µL of lysis buffer.  Temperature cycling was then performed between 
65 °C and 96 °C for a total of 23.5 min (65 °C for 15 min, 96 °C for 2 min, 65 °C for 4 
min, 96 °C for 1 min, 65 °C for 1 min, 96 °C for 30 s) by transferring tubes between two 
heating blocks.  This crude cell lysate was either used directly for nucleic acid 
amplification or for RNA purification.  For experiments where pure RNA was required for 
off-chip controls, a commercial RNA purification kit (RNeasy Mini Kit, Qiagen, U.K.) was 
used according to the manufacturer’s recommendations.  Cell lysate samples were 
stored at -15 °C until required. 
3.1.5 On-Chip RNA Purification  
 
The on-chip RNA purification protocol was adapted from previously reported techniques; 
[4-6] the on-chip protocol is described in the integrated microfluidic device operation 
section below.  To obtain elution profiles, RNA was eluted by flowing dH2O through the 
silica bead chamber and collecting in sequential 5 µL fractions.  1 µL of each fraction 
was used for RNA quantification with the Quanti-iT® RNA Assay Kit (Molecular Probes) 
according to the manufacturer’s protocol.  The fluorescence was read on an Infinite™ 
200 reader (Tecan, Switzerland). 
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3.1.6 Real Time NASBA 
 
All reagents required to perform the NASBA were supplied as part of a NucliSens Basic 
Kit (bioMérieux, UK), except primers and molecular beacon probes, which were supplied 
by MWG Biotech (Germany).  The NASBA mix was prepared according to the 
recommendations of manufacturer; the final concentration of each primer was 5 µM, and 
5 µM for the molecular beacon probe (FAM fluorophore, BHQ1 quencher; detection at 
530 nm).  Both primers and the molecular beacon probe were designed for the specific 
detection of E. coli based on the RiboSEQ platform [1].   
 
5'-AATTCTAATACGACTCACTATAGGGAGATAGTCGCAAACGACGAA-3' was used as 
the forward primer, 5'-CTACATCCTCGGTACTACA-3' as the reverse primer, and  
5'-FAM-CCAGCTAGCCTGATTAAGTTTTAAGCTGG-BHQ1-3' as the molecular beacon 
probe.  These primers and probes were used for both on-chip and off-chip experiments.  
To allow comparison with on-chip results, off-chip real time NASBA was performed using 
a LightCycler 480 Real time PCR System (Roche Applied Science, U.S.A.); the reagent 
mixture, without enzymes, was mixed with the RNA template and heated on a block 
heater at 65 ºC for 5 min and at 41 ºC for 5 min.  Next, the enzymes were added, the 
NASBA mixture was heated for 5 min at 41 °C, loaded into a 96-well plate, and placed in 
the LightCycler system.  The fluorescence (530 nm) was measured every minute for 90 
min. For each on-chip NASBA experiment, an E. coli tmRNA-positive control and a no-
template negative control were amplified off-chip at 41 °C in the LightCycler in 20 µL 
volumes to verify NASBA reaction mixture performance. 
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Figure 3.3 Representation of integrated microfluidic NASBA operation; all ports except 
for I, WO, and NP are sealed.  (A) Sample mixture is pumped through the RNA 
purification chamber.  (B) Washing solution is pumped through the purification chamber 
to remove unbound substances.  (C) Bound RNA is eluted with primer-containing 
solution.  (D) The mixture is heated to 65 ºC for 5 min.  (E) NASBA enzymes are added 
through the NP port.  (F) The fluids are mixed and incubated at 41 ºC to drive the 
amplification process. Reproduced from REF [1]. 
 
3.1.7 Integrated Microfluidic Device Operation 
 
The RNA purification and NASBA chambers were characterised in this work; therefore, a 
simple connection scheme was used, in which a syringe pump (Pump 11 Pico Plus, 
Harvard Apparatus U.S.A.) was connected to the I port (Figure 3.3A) through a 250 µL 
tube coil (1/32" inside diameter silicone platinum-cured tubing, 95802-01, Cole Parmer, 
U.S.A.).  The opening and closing functions were accomplished manually using 
adhesive tape (from Roche LightCycler 480 plates kit, Fannin Healthcare, Ireland) to 
seal and open ports as required.  Prior to use of the device for RNA purification and 
amplification, the NASBA chamber was filled with 1 µg/µL bovine serum albumin (BSA) 
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solution (Sigma Aldrich, U.S.A.) and the entire device was soaked in dH2O for at least 
12 hr at room temperature.  Before operation of the device, the BSA solution was rinsed 
from the NASBA chamber with approximately 1 mL of dH2O.  The entire device was 
filled with dH2O and all ports except for I and WO were sealed.  The I port was 
connected to the syringe pump with the 250 µL tube coil preloaded with the necessary 
reagents.  Between each reagent plug in the tube coil, a 5 µL air spacer was injected [7].  
The WO port was connected to waste.  Before each experiment, the purification 
chamber silica beads were conditioned for RNA capture by flowing 100 µL of 6 M GuHCl 
(Sigma Aldrich) for 20 min at 5 µL/min.  Pre-mixed sample solution (10 – 40 µL of the 
RNA-containing sample mixed with 90 µL of 6 M GuHCl) was then pumped through the 
extraction chamber (Figure 3.3A) at 5 µL/min.  After the RNA bound to the beads (20 
min), other substances (cellular debris, proteins, etc.) were washed away by flowing 
through 100 µL of 80% isopropanol alcohol (IPA) at 17 µL/min (Figure 3.3B).  After 
washing left-over IPA is removed and dried with the 5 µL air spacer.  Next, the NP port 
was opened and the WO port sealed so that the bead-bound RNA sample could be 
eluted from the beads by pumping through approximately  
11 µL of the NASBA reagent mixture (Figure 3.3C).  All ports were sealed and the 
mixture was heated to 65 ºC for 5 min (Figure 3.3D) on a peltier device heating system 
(PE120, Linkam Scientific Instruments Ltd. UK) to denature secondary and tertiary RNA 
structures that could hinder subsequent annealing of primers during NASBA.  By 
opening the I and NP ports and connecting the previously described syringe pump, 2 µL 
of NASBA enzyme mixture were slowly added to the NASBA chamber through the NP 
port as shown in Figure 3.3E.  The enzymes were mixed with the reagent mixture by 
manually applying 40 2-Hz pressure pulses on the surface of the PDMS over the centre 
of the NASBA chamber (Figure 3.3F).  
 
Next, all ports on the chip were sealed and the chip was mounted on an inverted 
fluorescence microscope (Olympus IX81) fitted with an incubation chamber (Solent 
Scientific, UK) and incubated at 41ºC for 90 min (a heated microscope stage can serve 
the same purpose as the incubator).  During the incubation  time, the NASBA chamber 
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was irradiated once per minute with a 492 nm excitation beam (excitation filter BP492/18 
with a xenon light source, CellR MT20, Olympus) for 230 ms; 530 nm fluorescent light 
was sampled through a filter cube (U-MF2, Olympus) with a CCD sensor (Hamamatsu 
C4742-80-12AG).  As the microscope field of view with a 4x objective covers about 1/5 
of the NASBA chamber area, 5 images of the chamber (centre, top, bottom, left, and 
right side) were obtained for each minute of incubation.  Real time NASBA curves were 
calculated from the average fluorescence as a function of time from the sets of acquired 
images.  To avoid contamination, each reaction was performed in a previously unused 
device. 
3.2 iNASBA array device 
 
The integrated NASBA array (iNASBA array) device demonstrates the merging of 
cellular and molecular functionalities into a single chip enabling from sample-in to 
experiment and answer-out capabilities is presented. The iNASBA array monolithically 
integrates microfluidic dynamic cell culture, cell stimulation, cell labelling, lysis, and real 
time NASBA based RNA analysis. By multiplexing this integrated functionality in an 
array, the device can be used for high content screening, gene expression profiling, and 
bioanalytical diagnostics. Furthermore, the microfluidic implementation of these 
procedures has the potential for enhancing assay reproducibility and obtaining more 
quantitative results [8] relative to the classical analytical procedures. 
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Figure 3.4 Integrated and multiplexed microfluidic NASBA array (iNASBA array) (A) 
Photograph of a row of 8 chambers with hydrostatic perfusion pipette tips filled with red 
food dye (scale-bar: 9 mm). (B) Design of each microfluidic NASBA element; scale-bars 
are equal to 200 µm.   
 
 
3.2.1 Device Design 
 
A completely integrated and multiplexed device is shown in Figure 3.4A (for detailed 
design schematic please see the attached file: “iNASBA array device.dwg”). Eight 
identical NASBA element modules are multiplexed with the same distribution as a 96 
well plate, which enables sample loading to be done with a standard 8-channel pipette. 
Each NASBA module (Figure 3.4B) consists of: a cell retention and culture reservoir (~ 4 
nL) for capturing the cell from the flow, culturing, lysis, and finally for performing real 
time NASBA; large and small particle filters for filtering debris from the culture media and 
prevent clogging in the cell capture and culture reservoir; lysis and NASBA mixture 
reservoir channels (~ 8 nL each) for storing and injecting the lysis and NASBA mixtures; 
chambers 1 & 2 containing the air volume which, when placed on top of localised 
(A) 
(B) 
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heating electrodes, expands and pumps out the fluid through the lysis and NASBA 
mixture reservoir channels. All microchannels and microchambers exhibit a height of 40 
µm, which was selected so that cancer cells which have an approximate diameter range 
of 5-20 µm can easily flow through the system. Additionally, the 40 µm height is readily 
achieved with SU8 surface micromachining. 
 
Cell trapping is done using a sieve structure composed by a set of pillars at the end of 
the culture chamber (Figure 3.4B) with a 5 µm inter-pillar spacing. The device is made of 
two layers (Figure 3.4A). The top PDMS layer accommodates the fluidic structures 
which are sealed by a glass slide attached to the bottom. During the cell culture phase 
the entire device is placed in a standard incubator were, if required, the partial CO2 
pressure can be controlled. 
 
During the real time NASBA analysis phase, the device is mounted on a standard 
automated temperature controlled fluorescence microscope stage and the change in 
fluorescence intensity of each NASBA chamber is measured as a function of time. To 
simplify the operation the device is designed in such a way that the fluidic resistivity of all 
the inlets is equal and low enough so that the pressure generated by a standard pipette 
is sufficient to drive fluids into the device. This enables all fluid loading of the device to 
be done directly by a standard pipette. Furthermore, when the filled pipette tips are left 
plugged into the inlets, they function as gravity driven pumps (Figure 3.4A) which are 
used for cell loading and the perfusion of culture media, drugs and labelling dyes. Each 
row of 8 culture chambers is connected to a common outlet which is connected through 
a flexible tube (Figure 3.4A) to a waste container. By varying the height and diameter of 
the outlet tube the perfusion flow velocity can be controlled. 
3.2.2 Operation 
 
All fluid loading into the device is done by connecting a standard pipette directly in the 
inlet. Before starting the experiments localised heating electrodes are placed under the 
air chamber 1 and 2 of all the NASBA elements. Next, the lysis and NASBA mixtures are 
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loaded. Initially the device is empty and air filled, then the real time NASBA mixture is 
flown into the inlet (Figure 3.5). This fills the device including the lysis and NASBA 
reservoirs with real time NASBA mixture. The lysis mixture is injected into the device 
and the excess NASBA mixture flushed out. The NASBA mixture in the lysis reservoir is 
replaced with lysis mixture by activating the heating electrodes under the air chamber 2. 
This causes the air in the chamber to expand, push out and empty the reservoir channel. 
Then the heating electrodes are turned off and the lysis mixture allowed to enter the 
lysis mixture reservoir channel. 
 
Figure 3.5 Micrographs of reagent loading and injection tests with food dye. Firstly the 
NASBA mixture (dark dye) is filled (1), through the main inlet. By flushing with water (2) 
and activating the heating electrode in the air chamber 2, the NASBA mixture that has 
entered the lysis reservoir is removed (3). Then lysis mixture can be filled. Finally the 
NASBA mixture is injected and mixed into the culture chamber by activating the heating 
electrode under the air chamber 1 (4). (Scale-bar:100 µm) 
 
 
The pipette tip that is used to flow in the lysis mixture is left plugged into the inlet (as in 
Figure 3.4A), emptied and filled up with media from the top. This establishes a gravity 
driven flow of culture media which is left to run for 10 minutes. Any left over lysis or real 
time NASBA mixture in the cell culture chamber is flushed away with the gravity driven 
flow of culture media. At this stage approximately 500 cells in 5 µL are loaded by gently 
pipetting them into the bottom of the plugged in tip. The gravity driven flow will gently 
take the cells into the cell capture and culture chamber.  Any cell stimulating drugs or 
cell staining dyes can be loaded directly into the plugged in pipette tip and the gravity 
driven flow will perfuse them over the cells. After culturing and drug stimulation the lysis 
mixture is released by activating the heating electrode under the air chamber 2. Finally 
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the real time NASBA mixture (Figure 3.5-4) is precisely released and diffusion mixed 
(Figure 4.5) into the culture chamber by activating the heating electrode under air 
chamber 1 for 15 s. The whole device is then heated for 5 minutes on a hot plate at 55 
°C and then placed on a 41 °C thermally controlled fluorescence microscope stage and 
the change in fluorescence from each NASBA chamber is measured as a function of 
time. During the loading process a large portion of the NASBA mixture is flown into the 
device outlet and only a small part (approximately 2 nL) is loaded into the NASBA 
mixture reservoir. Considering the total chamber volume of ~200 nL, which is 100 time 
less than the total NASBA mixture volume used in the conventional off-chip case (app. 
20 µL). Furthermore due to the small cross sectional area of the reservoir channels 
diffusion loss of the reservoir contents is kept to a minimal. 
3.2.3 Fabrication  
 
The top layer with the microfluidic channels was fabricated using standard soft 
lithography replica moulding technique [3].  A mould was created through a single-layer 
process using negative photoresist, SU8-3050 (Microchem U.S.A.) and the 
manufacturer recommended protocol (with a spin rate of 2000 RPM) to create 40 µm 
high features on a clean silicon wafer. PDMS (Sylgard 184, Dow Corning) was prepared 
according to the manufacturer’s instructions and used to inversely replicate the mould. 
PDMS was used because of its biocompatibility [2] and its ease of bonding to glass. 
Fluid inlets and outlets were punched with a 1 mm outer diameter flat-tip needle for tube 
connections. 
 
A 75x25x1 mm3 glass slide (VWR International Inc., U.S.A.) and the PDMS structures 
were treated with UV ozone (PSD-UV, Novascan Technologies, Inc., Iowa, US.) for 10 
minutes before bonding for 2 h at 90 ºC.  Then 0.01 % poly-L-lysine (Sigma Aldrich, 
Ireland) solution was flown into the device and left at room temperature for 2 hours to 
coat the device. Any uncoated poly-L-lysine was flushed away by deionised water 
(dH2O). Finally, for the localised heating electrodes, a 2 micron high electrode feature 
layer was developed on a continuous gold coated glass slide (Part. No. 820.003 Lebow 
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Company, CA, U.S.A.) using Microposit S1818 photoresist (Chestech Ltd., UK) and the 
manufacturers instructions. The exposed gold and chrome layers were etched away with 
gold etchant solution and chromium etchant solution (Sigma Aldrich, Ireland) in less than 
40 sec. The Microposit S1818 photoresist left on the electrodes was washed away with 
70% Propanol-2 solution (Sigma Aldrich, Ireland). 
3.3 iCell array device 
 
The design of a multiplexed integrated cell based assay system (iCell array) with several 
readout capabilities such as real time Nucleic Acid Sequence-Based Amplification 
(NASBA) and immuno-fluorescent (IF) protein expression detection is presented. The 
microfluidic system is capable of performing 512 dynamically configurable integrated cell 
based assays coupled with real time NASBA and IF analysis (see Figure 3.6, for 
detailed design schematic please see the attached file: “iCell array device.dwg”). It has 
been designed for simple, efficient and shear stress free loading of cells and reagents 
that can be done with existing laboratory tools such as standard multichannel pipettes or 
pipetting robots. The device has an onboard gravity driven flow control system making it 
independent of cumbersome syringe pumps or other active macro-scale flow control 
components such as pressure sources and solenoid valves. This allows the device to be 
self contained, mobile and directly used in standard laboratory cell culture incubation 
chambers and microscope systems. 
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Figure 3.6 iCell array (A) consists of 64 processing modules (B) that can perform 64 
independent simultaneous integrated assays. For statistical replication purposes each 
module consists of 8 parallel and equally distributed (C) processing chambers that 
contain a central trench structure (D). Each processing chamber can execute integrate 
any sequence basic unit operations (E) The function of each processing chamber 
depends on the sequence and timing of each gravity driven unit operation and the input 
fluid.   
 
3.3.1 Fabrication 
 
The microfluidic device was fabricated using standard soft lithography replica moulding 
techniques [3].  A mould was created through a double-layer process (Figure 3.7) first 
using negative photoresist, SU8-3050 (Microchem U.S.A.) and then SU8-2150 
(Microchem U.S.A.) both layers were  deposited onto a clean silicon wafer using a spin 
coater (P6700 Specialty Coating Systems, Inc., U.S.A.).   
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Figure 3.7. The fabrication process of a iCell array has been optimized to simplify 
alignment and complexity. It consists of 2 layers of PDMS (a fluidic layer and a lid/inlet 
layer) and support glass layer. 
 
 
The first layer photo resist (5 mL) was spread onto the wafer at 500 RPM for 10 s, and 
the rotation rate was ramped at an acceleration of 350 RPM/s to 4000 RPM, at which 
rate the sample was spun for 30 s to form a 40 µm layer.  The wafer was soft baked at 
95 ºC for 15 min followed by UV-exposure for 30 s at 9.5 mW/cm2 using a Karl-Süss 
KSM MJB-55W mask aligner.  The wafer was post-exposure baked for 1 min at 65 ºC 
and 62 min at 95 ºC, allowed to cool to room temperature, developed in Microposit EC 
Solvent (Chestech Ltd., UK) developer and sonicated (Branson 5510, Kell-Storm, USA) 
for 4 min, and blown dry with nitrogen. The second layer photo resist (5 mL) SU8-3025 
(Microchem U.S.A.) was spread onto the patterned wafer at 500 RPM for 10 s, and the 
rotation rate was then ramped at an acceleration of 350 RPM/s to 4,000 RPM, at which 
rate the sample was spun for 3 s.  The wafer was then soft baked at 95 ºC for 10 min. 
Then another layer of photo resist (5 mL) SU8-2150 (Microchem U.S.A.) was spread 
onto the wafer at 500 RPM for 5 s, and the rotation rate was then ramped at an 
acceleration of 200 RPM/s to 1,500 RPM, at which rate the sample was spun for 30 s to 
form a 250 µm layer. The wafer was then soft baked at 65 ºC for 6 min. and then at  
105 ºC for 15 min, then aligned and UV-exposed for 70 s at 9.5 mW/cm2.  The wafer 
was post-exposure baked for 6 min at 65 ºC and 12 min at 95 ºC, allowed to cool to 
room temperature, developed in Microposit EC Solvent (Chestech Ltd., UK) developer 
for 12 min, and blown dry with nitrogen. The two layer SU-8 mould was coated with 
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perfluoro-silane in a vacuum chamber for reducing the PDMS adhesion. PDMS 
prepolymer (Sylgard 184, Dow Corning) was prepared at 10:1 (w/w) ratio, degassed in a 
vacuum chamber for 30 min, then spin coated (500 RPM for 30 sec) on the SU8 mould 
and cured in a 100 ºC oven for 5 min. producing an ~500 µm thick fluidic layer.  The 
PDMS was then carefully peeled off the mould. As the upper seal a second non 
patterned wafer was also coated with a 2 mm thick layer of PDMS pre-polymer and 
cured at 80 ºC for 4 hrs. Fluid inlets and outlets were punched into the 2 mm thick layer 
upper layer. A flat-tip needle was used for making the inlets (1.3 mm OD) and outlet (3 
mm OD) holes.  The device was assembled by firstly placing the fluidic layer (with the 
fluidic structures exposed on the upper side) on a 500 µm thick 4 inch glass wafer for 
support. The assembly was treated with O2 plasma (PDC-002 Harrick Scientific Corp. 
USA) for 2 min. after which the upper PDMS layer (containing the inlets and outlets) was 
manually aligned and bonded at 60 ºC for 2 hrs. The entire device was degassed 
overnight for removing bubbles that may form between the glass and PDMS. 
3.3.2 Device Loading and Flow Control 
 
Firstly the device is primed with PBS, which is done by placing the empty chip into a 
vacuum desiccator and degassing it for 10 min. This will remove any bubbles formed 
during the initial fluid loading process (movie SM1). Then a 1000-µL Eppendorf pipette 
loaded with 100 µL of PBS is inserted into each inlet that will be used during the 
experiment. Using the pipette the PBS solution is driven into the device until a droplet is 
formed in the outlet, after which the pipette tip is released form the pipette and left 
inserted into the device inlet. This forms the fluid column that will drive the fluid flow. The 
height of the fluid column and thus the device flow velocity can be regulated (Figure 
5.6A) by inserting or removing fluid from the top of the pipette tip with a second long tip 
pipette (0.5 mm round tip Corning® gel-loading tips, Sigma Aldrich, USA). Cells or other 
particles are loaded by firstly establishing a flow with a fluid column height and then 
using the long tip pipette to inject the cells at the bottom of the fluid column. For general 
eukaryotic cells (MCF7, HeLa, etc.) experiments, ~2000 cells in 10 µL of culture media 
were loaded into each processing module. Cell numbers were quantified using a 
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hemocytometer (BS.748 Hawksley, UK) according to the manufacturer’s instructions. 
Any additional or non-loaded cells can be removed from the inlet by extracting them 
from the bottom of the fluid column with long tip pipette (0.5 mm round tip Corning® gel-
loading tips, Sigma Aldrich, USA). The PBS fluid column is then replaced with culture 
medium.  
3.3.3 Device Coating for Adherent Cell Culture 
 
To prepare the device for adherent cell culture and stimulation experiments the 
processing chambers are coated with a poly-L-lysine layer by allowing the 1% poly-L-
lysine solution (Sigma Aldrich, USA) to flow continuously for 2 hrs at room temperature. 
Then the poly-L-lysine is replaced with 300 µL of PBS (Sigma Aldrich, USA) and left to 
rinse the device for 2 hrs. The remaining PBS is replaced with 300 µL of cell culture 
medium. 
3.3.4 Cell Culture 
 
MCF7, HeLa, 59M and U266 cells were cultured on and off chip using a CO2 
independent medium supplemented with 10% bovine serum albumine, L-Glutamine and 
penicillin/streptomycin. In the on-chip cell culture and stimulation experiments the entire 
device was incubated at 37 ºC in an inverted fluorescence microscope (Olympus IX81) 
fitted with an incubation chamber (Solent Scientific, UK). 
3.3.5 Cell Staining and Drugs 
 
Cells were stained on-chip by flowing over them a PBS solution containing fluorescent 
staining agents. For live cell staining 4 µL/mL of Calcine AM (Sigma Aldrich, USA) was 
used while for dead cells 4 µL/mL of propidium iodide (Sigma Aldrich, USA) nuclear 
stain was used. Both stains were dissolved together in PBS and 300 µL loaded into 
each fluidic column. After 20 minutes fluorescent images were acquired of each 
processing chamber. In cell stimulation experiments the drug or stimulating agent is 
dissolved in the cell culture medium according to the required concentration. Cells would 
receive the stimulation drug or agent after a 24 hrs drug free cell culture period.   
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3.3.6 Cell Lysis 
 
For the E. coli experiments cell lysis was performed off chip using MicroLYSIS PLUS 
buffer (Microzone Ltd., UK) according to the manufacturer’s recommendations.  An 
overnight culture of E. coli (OD600 of 1.36) with a cell density of 3.4 x 108 colony forming 
units (CFU)/mL (based on plate counts) was centrifuged at 10,000 rpm for 5 min, 
producing a pellet volume of 5 µL, and mixed with 40 µL of lysis buffer.  Temperature 
cycling was then performed between 65 °C and 96 °C for a total of 23.5 min (65 °C for 
15 min, 96 °C for 2 min, 65 °C for 4 min, 96 °C for 1 min, 65 °C for 1 min, 96 °C for 30 s) 
by transferring tubes between two heating blocks.  This crude cell lysate was either used 
directly or diluted with PBS to produce required cell concentrations. Cell lysate samples 
were stored at -15 °C until required. For the on-chip eukaryotic cell lysis experiments 
MicroLYSIS PLUS buffer was mixed with the NASBA primers (5 µM each primer). The 
200µL of lysis mixture was loaded into the fluid column and allowed to flow into the 
processing chamber for 5 min. after which the flow was stopped and the device mounted 
on a hot plate at 65 °C for 5 min. 
3.3.7 Real Time NASBA 
 
All reagents required to perform the NASBA were supplied as part of a NucliSens Basic 
Kit (bioMérieux, UK), except primers and molecular beacon probes, which were supplied 
by Sigma Aldrich (UK). The NASBA mix was prepared according to the manufacturer’s 
recommendations; the final concentration of each primer was 5 µM, and 5 µM for the 
molecular beacon probe.  For the E. coli detection the design of both primers and the 
molecular beacon probe was taken from Dimov et al. 2008 [1]. For the estrogen receptor 
alpha detection, the primer and the molecular beacon probe designs are described in 
Verjat et al. [9]. Off-chip real time NASBA was performed using a LightCycler 480 Real 
Time PCR System (Roche Applied Science, U.S.A.); the reagent mixture, without 
enzymes, was mixed with the RNA template and heated on a block heater at 65 ºC for 5 
min and at 41 ºC for 5 min.  Next, the enzymes were added, the NASBA mixture was 
heated for 5 min at 41 °C, loaded into a 96-well plate, and placed in the LightCycler 
system.  The fluorescence (530 nm) was measured every minute for 90 mins.  
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For On-Chip experiments the reagent mixture was mixed off chip with the enzyme 
mixture to produce a master NASBA mixture. This was then flown into the chip for 15 
min at ~200 µm/sec. In the case of the E. coli detection experiments the reagent mixture 
contained varying concentrations of E. coli lysate (for the negative control RNA free 
water replaced the E. coli lysate). After that the device is mounted on a thermally 
controlled inverted fluorescent microscope and the green and red fluorescence imaged 
every minute in every processing chamber.  Real time NASBA curves were calculated 
from the average fluorescence as a function of time from the sets of acquired images. 
3.3.8 Cell Fixing, Permeabilization and Immuno-fluorescent 
staining 
 
Cells captured within the chip were fixed with 4% paraformaldehyde for 25 min at 100 
µm/s flow rate. After washing once briefly with PBS-T (Dulbelcco's PBS containing 
0.01% Triton X-100), the cells were treated with 0.05% Triton X-100 in PBS for 10 min 
for permeabilization at 200 µm/s flow rate. The cells were washed once briefly with PBS-
T, followed by blocking in PBS-T containing 5% fetal bovine serum (FBS) for 30 min at 
room temperature and a flow rate of 200 µm/s. The cells were then incubated for 1 hour 
at room temperature with anti-ERα antibodies (F10, Santa Cruz, CA, USA) diluted at 
1:50 in PBS-T containing 1% FBS at 200 µm/s flow rate.. The cells were washed with 
PBS-T, for 20 min at 600 µm/s flow rate. Then the cells were incubated for 15 min at 
room temperature with Alexa Fluor 488 fluorescent dye-conjugated secondary 
antibodies (Molecular Probes Inc., Eugene, OR, USA) (1:200) in PBST containing 1% 
FBS at 200 µm/s flow rate. The cells were washed with PBS-T for 1 hr at 600 µm/s flow 
rate, before staining with Propidium Iodide. Immunofluorescent staining(s) were 
observed under Olympus IX81 Fluorescence Microscope with Optronics MagnaFire 
digital camera (Microscope Image Centre, UVM). 
3.3.9 Device Read Out 
 
For readout the device is mounted on a thermally controlled inverted fluorescent 
microscope. In our case an Olympus IX81 fitted with an incubation chamber Solent 
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Scientific (UK) was used. All acquisitions (bright field, and fluorescent) were done with a 
CCD sensor (Hamamatsu C4742-80-12AG) and through the 10x objective. For green 
fluorescence imaging an excitation filter BP492/18 with a xenon light source, CellR 
MT20 (Olympus) and a U-MF2 filter cube (Olympus) was used. For red fluorescence 
imaging an excitation filter BP540/10 with the previously mentioned xenon light source 
and a U-MW1GA3 filter cube (Olympus) were used. When scanning multiple processing 
chambers a programmed motorized stage was used to position and focus the objective 
over each processing chamber. The image analysis and motorized stage programming 
was done using the ImageJ and the Cell R software packages (Olympus).   
3.3.10 Computational Fluid Dynamics 
 
The flow patterns are calculated by means of two-dimensional Navier-Stokes equations 
of the total continuity, energy and momentum.  
 
u∇=0    (eq. 2.1) 
FuIuu
t
u +∇+−⋅∇=∇⋅+∂
∂ ][ ηρρρ
 
(eq. 2.2) 
 
where u is the velocity of the mixture flow, ρ is the flow density, I is the inertia force, µ is 
the dynamic viscosity, and F is the external body force. To estimate particle trapping 
efficiency in this trench system, the Kahn and Richardson force (eq. 2.14) for particle 
tracing was calculated. Mass transfer and component mixing are estimated from mass 
transfer equation (eq. 2.10). Simulations focused on the key factors of particle capture 
and species mixing within the trench geometry. In order to predict the key design 
parameters simulation focused on the effects of the geometrical parameters, flow 
velocity, particle size, particle trapping efficiency and the mixing of fluid components 
(see Table 3.1). The pressure boundary condition was used for the inlet and the outlet. 
In the computational analysis, 50 particles were tracked and the boundary conditions 
were estimated as listed in Table 3.2. The trench simulation was performed in a two-
dimensional tri-angular grid consisting of 1,168 cells for estimation of trapping efficiency 
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and 4,905 cells for estimating the mixing effects using a commercial computational fluid 
dynamics (CFD) code, COMSOL ver 3.4 (COMCOL LAB, Stockholm, Sweden) and 
CFD-ACE V2008.3 (ESI-Group, Huntsville, AL, USA), respectively. The semi-implicit 
pressure linked equation (SIMPLE) algorithm was applied to solve the momentum 
equation. The calculation for each case took about 5 min of running time on a Intel Xeon 
E5420 @ 2.50 GHz. 
 
Table 3.1. Simulation Parameters  
Parameter Values 
Trench height 0.25, 2.5, 6.25, 12.5, 25 
Trench length 0.25, 2.5, 6.25, 12.5, 25 
Velocity 9.0 × 10
-2, 1.8 × 10-3, 9.0 × 10-3, 9.0 × 10-4, 
9.0 × 10-5 
Particle diameter, Dp/H0 at D = 1.9× 105, 2.5 × 10
-3, 7.25 × 10-3, 2.5 × 10-2, 7.25 × 10-2, 
2.5 × 10-1, 
Particle density, D  1.9× 10
2, 1.9× 103, 1.9× 104, 1.9× 105, 1.9× 
106, 
 
 
Tn is the time to complete species replacement within the trench. It is defined as the 
time that it takes for a new added species to reach a stable final concentration in the 
trench and is calculated as the difference in the time between the added species 
normalized average concentration of 1 x 10-4 and 0.99 at a given constant flow rate of 
the added species. Thus Tn depends amongst other things on the flow velocity of the 
added species, the diffusion coefficient of the added species, the trench geometry and 
the inlet and outlet flow path lengths.    
 
Table 3.2. Boundary Condition 
Boundary Condition Value 
Inlet Pressure boundary, Pin 
Normal 0.04, 0.4, 4, 
20, 40 Pa  
Outlet Pressure boundary, Pout 0 
Wall No slip - 
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Chapter 4: Integrated Microfluidic Device for RNA 
Extraction and Real Time NASBA 
 
A characterization is presented of the first integrated microfluidic tmRNA purification and 
nucleic acid sequence-based amplification (NASBA) device incorporating real time 
detection. The real time amplification and detection step produces pathogen-specific 
response in less than 3 min from the chip-purified RNA from 100 lysed bacteria.  On-
chip RNA purification uses a new silica bead immobilization method.  On-chip 
amplification uses custom-designed high-selectivity primers and real time detection uses 
molecular beacon fluorescent probe technology; both are integrated on-chip with 
NASBA.  Present in all bacteria, tmRNA (10Sa RNA) includes organism-specific 
identification sequences, exhibits unusually high stability relative to mRNA, and has high 
copy number per organism; the latter two factors improve the limit of detection, 
accelerate time-to-positive response, and suit this approach ideally to the detection of 
small numbers of bacteria. Device efficacy was demonstrated by integrated on-chip 
purification, amplification, and real time detection of 100 E. coli bacteria in 100 µL of 
crude lysate in under 30 min for the entire process.  
4.1 Characterization of the NASBA Chamber 
 
The NASBA chamber (see Section 3.1 for device and experimental details) is the central 
sensing unit in the integrated device.  It was characterized initially by extracting and 
purifying total RNA from E. coli off chip, then preparing serial dilutions of the total RNA 
and loading into multiple devices.  The template RNA dilutions were mixed on-chip with 
the NASBA mix (enzymes, primers, molecular beacons, etc.) as described in Section 
3.1, then pumped to the NASBA chamber.  All experiments were performed in triplicate 
and included a negative control where the RNA template solution was replaced with 
sterile RNA-free water (Molecular Biology Grade Water, Sigma Aldrich, U.S.A.). 
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Figure 4.1. Characterization of real time NASBA reaction for off-chip-purified E. coli 
RNA template. (A) Fluorescence intensities in arbitrary units (AU) were plotted over the 
course of the NASBA reaction.  Experiments were performed in triplicate with different 
numbers of template molecules from total RNA extractions (ranging from 102 to 106 E. 
coli cells, as indicated). (B) Time-lapse images showing the fluorescence increase of the 
integrated NASBA chamber entrance loaded with total RNA equivalent to 100 E. coli 
(right of each frame) and the negative control (left of each frame). Reproduced from REF 
[1]. 
 
 
Figure 4.1A shows a clear relationship between the rate of fluorescence increase and 
the input template RNA concentration.  Error bars, the standard deviations of the 
triplicate measurements, show that the results are reproducible (average variation of ± 
6%).  Similar results were obtained from positive control experiments performed on the 
Roche LightCycler 480.  The NASBA chamber has an approximate volume of 2 µL, one 
tenth of the standard 20 µL NASBA reaction volume.  The data suggest that the BSA-
treated and water-soaked PDMS chambers support an efficient real time NASBA 
reaction, notwithstanding its greater bio-chemical complexity relative to PCR: NASBA 
involves 3 enzymes, PCR only one. 
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4.2 Characterization of RNA Purification 
 
RNA loading, washing, and elution procedures were performed as described in Section 
3.1.5.  In order to characterize the RNA purification module, RNA was purified from the 
crude lysate of 107 E. coli cells and a total RNA elution profile was obtained by collecting 
consecutive 5 µL aliquots of the eluted solution and measuring the RNA concentration. 
 
While 1 µL of each 5 µL aliquot was used for RNA quantification with the Quanti-iT® 
RNA Assay Kit, RNA from another 2.5 µL aliquot was amplified by real time NASBA 
using the Roche LightCycler 480 and the end-point amplicon fluorescence recorded.  
The experiments were conducted on two different devices, and are summarized in 
Figure 4.2.   
 
As expected, the results show the amount of RNA is highest in the first elution fraction 
and decreases as elution continues.  The end-point amplicon fluorescence, however, is 
highest in the 3rd elution fraction (between the 10th and 15th µL). The 5 µL air spacers 
that separated the reagents did not cause any problems or bubble formation as they 
passed through the RPC, because the injected air plugs only passed through straight 
channels and a soft 90° turn geometry (from I to WO). Additionally the bead 
immobilisation method creates a layer of silica beads (see Figure 3.2.1 in Section 3.1) 
which leaves plenty of space for debris and air to pass through without leaving bubbles 
or clogging.  Since there is a trade-off between clogging probability and capture 
efficiency, the height of the purification chamber during manufacture can be adjusted to 
fine tune the free-flow space to minimise clogging and maximise capture efficiency.  
Although it was neither required nor used in our application, another advantage of the 
bead immobilisation method is that it allows the sample solution to flow back and forth 
over the same beads, increasing capture efficiency; immobilized beads’ extraction 
efficiency can be between 102- to 103-fold greater than non-immobilised beads [2].  
 
Since most inhibitors (including IPA) are washed away, there is a possibility that the 
elution time for the RNA fragments is size dependent; thus, our target fragments (363-
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nucleotide tmRNA molecules) mostly elute in the 3rd elution fraction.  Similar elution 
results and differences in amplicon and eluted RNA peaks were reported in a similar 
microfluidic device [3].  For the integrated operation of chips, the 3rd eluted fraction was 
used for downstream on-chip real time NASBA. 
 
To evaluate the integration of on-chip RNA purification with real time NASBA, crude 
lysates of E. coli cells (Figure 4.3) were prepared.  Three E. coli lysates from 102, 105, 
and 108 CFU were prepared together with a negative control (dH2O) as previously 
described.  RNA from the samples was purified and amplified using 4 separate 
microfluidic chips, one for each sample.  Real time NASBA results, Figure 4.3, show 
successful on-chip integrated RNA purification and real time NASBA.  The time taken for 
positive samples to reach above background fluorescence during real time NASBA 
amplification is known as the time-to-positivity or TTP and can be related to the initial 
amount of target RNA present in the sample.  The lysate from 100 E. coli cells was 
readily detected with a TTP of less than 3 minutes, suggesting a limit of detection 
significantly below 100 cells.  Note that since RiboSEQ targets are used, each E. coli 
contains approximately 500-1,000 copies[4] of tmRNA target fragment, so detection of < 
100 cells is not surprising.  This high copy number, along with the relatively high stability 
of tm-RNA, also increases the detection robustness, a critical factor in complex sample 
matrices such as blood.  The difference in end-point fluorescence displayed in Figures 
4.1A and 4.3 most likely results from differences caused by the change in the purification 
capacity between the two experiments; also, the method used to purify RNA is different 
for the two experiments.  These factors may influence the kinetics of the NASBA 
reaction and consequently the endpoint fluorescence.  Furthermore, the negative control 
fluorescence in the off-chip purification process (Figure 4.1A) is higher (2 AU) than on 
the on-chip purification (Figure 4.3).  Since the procedures were similar, the lower 
negative control fluorescence in the on-chip purification may be due to reduced 
contamination.  In the on-chip procedure, there are no sample pipetting or sample 
transfer steps after the purification.  Fluorophore bleaching can occur during the real 
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time NASBA reaction; to reduce this effect, the exposure time was limited to 230 ms for 
the data shown in Figure 4.3.  
 
The TTP for samples of crude E. coli lysate (Figure 4.3) demonstrates that the various 
cell numbers can be distinguished from the negative control in as little as 3 min, which, 
to the best of our knowledge, is more rapid than any previous report of on-chip 
amplification and detection from as few as 100 cells [5].  With this approach, the total 
time from “sample to answer” can be less than 30 min.  Table 4.1 shows the comparison 
of on-chip and conventional “off-chip” RNA purification and real time NASBA.  Compared 
to the conventional off-chip method, on-chip NASBA requires approximately 10 times 
less volume, and the resultant discrimination is approximately 10 times faster (3 min on-
chip, 15 – 25 min off chip; see Supporting Information).  Relative to conventional, off-
chip procedures, on-chip integration reduces the direct pipetting steps from 11 to 2 and 
the sample-transfer steps from 3 to 1, reducing significantly the likelihood of sample 
contamination. 
 
 
Figure 4.2.  Elution profile (grey bars with standard error variations) of total RNA 
extracted from crude lysate of approximately 107 E. coli shows total RNA concentration 
in each 5 µL elution fraction.  Blue data points with the standard error bars (right y-axis) 
show end-point NASBA amplicon fluorescence after a 90-min off chip real time NASBA 
amplification of 2.5 µL of each eluted fraction. Reproduced from REF [1]. 
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4.3 Integrated RNA Extraction and Real Time NASBA 
Operation  
 
To evaluate the integration of on-chip RNA purification with real time NASBA, crude 
lysates of E. coli cells (Figure 4.3) were prepared.  Three E. coli lysates from 102, 105, 
and 108 CFU were prepared together with a negative control (dH2O) as previously 
described.  RNA from the samples was purified and amplified using 4 separate 
microfluidic chips, one for each sample.  Real time NASBA results, Figure 4.3, show 
successful on-chip integrated RNA purification and real time NASBA.  The time taken for 
positive samples to reach above background fluorescence during real time NASBA 
amplification is known as the time-to-positivity or TTP and can be related to the initial 
amount of target RNA present in the sample.  The lysate from 100 E. coli cells was 
readily detected with a TTP of < 3 minutes, suggesting a limit of detection significantly 
below 100 cells.  Note that since RiboSEQ targets are used, each E. coli contains 
approximately 500-1,000 copies[4] of tmRNA target fragment, so detection of < 100 cells 
is not surprising.  This high copy number, along with the relatively high stability of 
tmRNA, also increases the detection robustness, a critical factor in complex sample 
matrices such as blood.  The difference in end-point fluorescence displayed in Figures 
4.1A and 4.3 most likely results from differences caused by the change in the purification 
capacity between the two experiments; also, the method used to purify RNA is different 
in each case.  These factors may influence the kinetics of the NASBA reaction and 
consequently the endpoint fluorescence. Furthermore, the negative control fluorescence 
in the off-chip purification process (Figure 4.1A) is higher (2 AU) than on the on-chip 
purification (Figure 4.3). Since the procedures were similar, the lower negative control 
fluorescence in the on-chip purification may be due to reduced contamination.  In the on-
chip procedure, there are no sample pipetting or sample transfer steps after the 
purification.  Fluorophore bleaching can occur during the real time NASBA reaction; to 
reduce this effect, the exposure time was limited to 230 ms for the data shown in Figure 
4.3.  
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RNA Purification and real time NASBA  
On-chip Conventional 
Total Reagent 
Volume Used 213 µL 2,450 µL 
NASBA Volume 2 µL 20 µL 
Time to Positive 3 min 25 min 
Table 4.1. Comparison of on-chip and conventional “off-chip” RNA purification and real 
time NASBA. Reproduced from REF [1]. 
 
The TTP for samples of crude E. coli lysate (Figure 4.3) demonstrates that the various 
cell numbers can be distinguished from the negative control in as little as 3 min, which, 
to the best of our knowledge, is more rapid than any previous report of on-chip 
amplification and detection from as few as 100 cells [5].  With this approach, the total 
time from “sample to answer” can be less than 30 min.  Table 3.1 shows the comparison 
of on-chip and conventional “off-chip” RNA purification and real time NASBA.  Compared 
to the conventional off-chip method, on-chip NASBA requires approximately 10 times 
less volume, and the resultant discrimination is approximately 10 times faster (3 min on-
chip, 15 – 25 min off chip; see Figure 4.4).  Relative to conventional, off-chip 
procedures, on-chip integration reduces the direct pipetting steps from 11 to 2 and the 
sample-transfer steps from 3 to 1, reducing significantly the likelihood of sample 
contamination. 
 
 
Figure 4.3. On-chip RNA purification and real time NASBA results.  On-chip analysis 
starts by loading crude cell lysate from E. coli, followed by RNA purification, then by 
NASBA with real time detection.  Each different sample was run on a on a fresh device. 
Reproduced from REF [1]. 
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4.4 Conclusion 
 
In this work, the first monolithic microfluidic platform that incorporates tmRNA 
purification, NASBA-based amplification, and real time fluorescence detection was 
demonstrated.  A unique new method of silica bead immobilisation simplifies device 
fabrication, effective sample purification, concentration, and operation.  The PDMS-
based microfluidic device uses a NASBA reaction volume of 2 µL, one tenth of 
conventional NASBA reaction volumes.  Result discrimination can be achieved within 
the first 3 min after NASBA is initiated, approximately one tenth of the time required in 
the off-chip NASBA reaction.  Direct sample manipulation and pipetting steps are 
reduced from 11 in the conventional case to 2 in the on-chip case. The fundamental 
components were characterised and their integrated operation demonstrated with real 
time detection of crude E. coli bacteria lysates from as few as 100 cells in a time of less 
than 30 min from sample loading to answer.  The design is not limited to microbial 
identification applications: it can be adapted for use as a general RNA purification, 
amplification, and detection platform for point-of-care molecular diagnostics and clinical 
applications. 
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Figure 4.4. Microfluidic RNA purification and Real Time NASBA protocol versus 
conventional RNA purification and Real Time NASBA protocol. In the microfluidic case 
approx. ten time less volume is used, results are obtained in approximately one tenth of 
the time and direct pipetting steps are reduced from 11 to 2. Reproduced from REF [1]. 
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Chapter 5:  iNASBA - Integrated NASBA Array For 
Quantitative Nucleic Acid Testing 
 
 
Characterisation of the integrated Nucleic Acid Sequence-Based Amplification 
(iNASBA) array is presented.  Since NASBA is an isothermal amplification method 
for nucleic acids, it does not require a thermo-cycler.  The amplification conditions 
for NASBA are constant and the optimization for each new assay is simpler than in 
the case of PCR. Moreover, NASBA is as sensitive as RT-PCR and allows selective 
amplification of single-stranded RNA in a background of comparable genomic 
dsDNA. The iNASBA array includes microfluidic dynamic cell culture, cell 
stimulation, cell labelling, lysis, and real time NASBA based RNA analysis on a 
single chip.  By multiplexing this integrated functionality the device can be used for 
high content screening, gene expression profiling, and diagnostics. Compared to 
conventional laboratory analysis, the iNASBA array may enable diagnostics for 
bacteria, viruses, and cancer markers at reduced costs, contamination and sample 
volumes. 
5.1 Hydrostatic Flow 
 
First the hydrostatic flow was charcterised (see Section 3.2 for device and experimental 
details). The outlet from the row of 8 chambers was connected to a flexible tube 
(silicone platinum-cured tubing, Cole Parmer, U.S.A.) with several internal diameters 
and heights. The device and tubes were filled with dH2O and left to flow until a 
droplet was formed at the waste container. The time and droplet volume were 
measured for each tube height and diameter.  
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Figure 5.1 Hydrostatic flow characterization through each culture chamber for different 
outlet tube inner diameters (0.02”-0.06”). 
 
 
The results (Figure 5.1) show that gravity flow can replace the entire volume of fluid 
in the culture chamber once per second in the slowest case (see Figure 3.4 in 
Section 3.2 i.e. approximatley 4 nL per second). 
5.2 Cell capture and Dynamic culture 
 
Then cell capture and dynamic culture experiments were done by loading the cells, 
capturing them and then leaving the media perfusion at 0.2 nL/min (as explained in 
Section 3.2) for 24 hours. The entire device was placed in a 37 °C temperature 
controlled incubation chamber (Solent Scientific, UK). HeLa and 59M cells were tested, 
the culture media used was Dulbecco modified Eagle medium (DMEM) supplemented 
with 2 mM glutamine, 10% fetal bovine serum (FBS), penicillin, and streptomycin. After 
the 24 hrs culture period cell viability was checked by using Calcine AM (4 mg/mL in 
PBS), that stains live cells with green fluorescence, and Propidium iodide (4 mg/mL in 
PBS) that stains dead cells with red fluorescence (Sigma Aldrich, Ireland) and injecting 
100 µL of the 2 dyes into the bottom of the plugged in pipette and allowing the gravity 
driven flow to perfuse the dye over the cells. Fifteen minutes after the dye injection, the 
red and green fluorescence in the culture chamber was checked using an inverted 
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fluorescence microscope (Olympus IX81). The results (Figure 5.2) show that the two cell 
types can retain viability after a 24-h culture. 
 
Figure 5.2. Cell culture for 24 hours demonstrating that several cell types can retain 
viability after being cultured with gravity driven perfusion flow, scale-bar: 150 µm. 
 
 
5.3 In chamber injection and mixing 
 
For RNA profiling the lysis and real time NASBA mixtures have to be injected into the 
culture chamber. This was tested with concentrated red food dye. The whole device was 
mounted on an inverted microscope (Olympus IX81) and the red dye was loaded only 
into the NASBA mixture reservoir (as explained in Section 3.2) and then the rest of the 
device was loaded with dH2O. For injection, the heating electrode under air chamber 1 
was activated with ~ 1.5 V and 10 mA for 15 seconds. This injected ~ 1 nL of dye into 
the cell capture and culture chamber (Figure 5.3). The results from Figure 5.3 show that 
the food dye, diffusion mixed, within 4 minutes. 
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Figure 5.3. In chamber mixing characterization; time lapse micrographs and 2D-
histograms of the culture chamber grey scale intensity distribution during the diffusion 
mixing of the fluids, scale-bar: 150 µm. 
 
 
5.4 Real Time NASBA in culture chamber 
 
After demonstrating the injection and mixing process, the on-chip real time NASBA was 
tested. This was done by injecting a pre-mixed real time NASBA mixture. Four mixtures 
(3 positive controls and a negative control) were injected into all the 8 culture chambers. 
All reagents required to perform the NASBA amplification were supplied as part of the 
NucliSens Basic Kit (bioMérieux, UK), except primers and molecular beacon probes, 
which were supplied by MWG Biotech (Germany).  The NASBA mix was prepared 
according to the manufacturer’s recommendations; the final concentration of each 
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primer was 5 µM, and 5 µM for the molecular beacon probe (FAM fluorophore, BHQ1 
quencher; detection at 530 nm).  
 
Both primers and the molecular beacon probe were designed for the specific detection 
of E.coli based on the RiboSEQ platform [1]. The positive controls contained crude 
E.Coli lysate (using the MicroLYSIS PLUS buffer, Microzone Ltd., UK) from approx. 107, 
105 and 103 E.Coli/mL while the negative controls had the lysate volume replaced with 
RNA-free water (Molecular Biology Grade Water, Sigma Aldrich, U.S.A.). The device 
was incubated at 41ºC in a thermally controlled inverted fluorescent microscope 
(Olympus IX81 with a Solent Scientific, UK, incubation chamber). 
  
 
Figure 5.4. Eight parallel on-chip microfluidic real time molecular beacon based NASBA 
reactions. (A) Fluorescence intensity plots in arbitrary units for each chamber over the 
course of the NASBA reactions. Each real time NASBA chamber was loaded with 
NASBA mixture and the following samples: Chamber 1 & 2-RNA free water (Neg. 
Control); Chamber 3 & 4-Lysate with approx. 107 E.Coli/mL; Chamber 5 & 6-Lysate with 
approx. 105 E.Coli/mL; Chamber 7 & 8-Lysate with approx. 103 E.Coli/mL (B) 
fluorescence in each NASBA chamber after 90 min. 
 
 
Every minute during the incubation each NASBA chamber was excited with a 492-nm 
beam (excitation filter BP492/18 with a xenon light source, CellR MT20, Olympus) for 
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190 ms and the 530 nm fluorescent light was sampled through a filter cube (U-MF2, 
Olympus) with a CCD sensor (Hamamatsu C4742-80-12AG). The change in the 
average fluorescence of each chamber was plotted over time (Figure 5.4) and shows 
that 8 parallel real time NASBA reactions were successfully performed in the 4 nL cell 
culture chambers. 
5.5 Discussion 
 
By utilizing gravity driven passive pumping 8 individually addressable culture media 
reservoir and pumping units can be densely integrated.  By varying the height of the 
outlet tube the flow velocity in the culture chambers can be adjusted.  The opened 
pipette tips allow for an easy, gentle and independent insertion of cells for loading the 
device, quick insertion of the stimulation drugs and labelling dyes. 
5.6 Conclusions  
 
An integrated NASBA array was designed and fabricated.  Proof of concept experiments 
have shown that each critical part of the device (Figure 5.1-5.4) can be successfully 
implemented.  These results demonstrate for the first time that cellular and molecular 
functions can be integrated onto a single device providing a potential tool of important 
value for high content screening, gene expression profiling, and diagnostics. Compared 
to conventional laboratory analysis, the iNASBA array could enable diagnostics of 
bacteria, viruses, and cancer markers with lower cost, less contamination, and smaller 
sample volumes. Even though the iNASBA array device has demonstrated the 
integration of cellular and molecular functions it still requires improvements in the design 
to achieve efficient shear-stress free cell loading and culturing. In the current 
implementation cell capture is done through size based exclusion where cells with a 
diameter of 5 µm or more are capture between the pillar gaps in the cell culture 
chamber. The problem with this type of cell capture is that it has low capture efficiency 
as most of the cells pass through the capture structures and into the outlet because 
most of the flow lines generally go around and pillars. Furthermore since PDMS is an 
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elastomer the pillars are flexible so the cells can squeeze thorough them. This is evident 
in Figure 5.2, where cells are squeezed between the pillars. A further disadvantage of 
the pillar design is that, as cells are captured they are effectively blocking the flow. This 
has important implications in the system flow control and the shear stress perceived by 
the cells. As a result a novel cell capture design will be presented in the following 
chapter that addresses most of these issues.   
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Chapter 6: iCell Array for Quantitative Cell Based 
Science 
 
 
Characterisation of the iCell array, is presented. This technology can perform completely 
integrated cell based assays with bio-analytical read-out protocols such as 
immunofluorescent imaging and NASBA based real time nucleic acid amplification. The 
iCell array enables parallel and configurable on-chip integration of complex procedures 
such as highly efficient capture of adherent and non adherent cells, perfusion cell 
culture, cytotoxicity assays, drug treatment, gene expression analysis, protein 
immunoassays and real time optical analysis. With on-board gravity driven flow control 
the device is simple and economical to operate with dilute samples (down to 5 cells per 
reaction), low reagent volumes (50 nL per reaction), highly efficient cell capture (~100% 
capture rates) and single cell protein and gene expression sensitivity. In the current 
design iCell array can process up to 512 10-nL reactions in a single chip and up to 64 
different user-defined integrated assays can be done simultaneously. To the best of my 
knowledge this is the first demonstration of a versatile fully integrated microfluidic array 
platform for dynamic cell studies that can be universally and economically used from 
routine applications in a biology laboratory to high content screenings. 
6.1 Characterisation of the iCell array operation 
 
 
The microfluidic iCell array (Figure 3.6 see Section 3.3 for device and experimental details) 
integrates a wide range of unit operations such as cell capture, filtering, reagent loading, 
mixing and controlling in a simple and configurable manner. This allows a seamless and 
flexible ‘on-chip’ integration of complex cell based or particle based assays together with 
bright field or fluorescent microscopic monitoring and real time detection of nucleic acid 
amplification or protein expression. The key to achieving this level of integration and 
flexibility lies in the ability to dynamically configure and execute a sequence of basic unit 
operations that are required in a complete assay, including experimental and analytical 
procedures. Assays are performed in the basic processing chamber structure (Figure 
3.6C-D). This structure consists of a chamber with a trench.  
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Figure 5.1. Photograph of the multiplexed integrated cell based assay system (iCell 
array) with fluid columns in 4 of the 64 processing modules. The integrated function of 
each processing module can be flexibly selected by the user and depends entirely on 
the sequence and timing of the fluid inputs. The basic steps required for three different 
cell based assays are illustrated. This versatility allows the user to combine cell 
stimulation and gene and protein expression analysis on a single microfluidic platform, 
Scale-bar: 9 mm. 
 
 
The key characteristic of the trench structure is that it allows the capture of cells and 
particles through gravitational sedimentation. In addition, a controlled flow over the top of 
the trench allows successive, diffusion driven loading, mixing and replacement of fluids 
within the trench. The required flow control is achieved by setting the height of a fluid 
column that generates the pumping hydrostatic pressure at the inlet (Figure 3.6 E). The 
fluid column is open on the top which allows for easy insertion of cells and the 
replacement of the fluid being loaded into the device. The operation paradigm of this 
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device is different to the more established “connection of specialized blocks” paradigm 
used in electronic integrated circuits and high density fluidic circuits (e.g. as in fluidic 
devices shown by Quake, et al. [1]). Instead, the device operates by using a single 
multipurpose structure that can retain cells or particles and delay the diffusion of 
molecules of interest in the same space where different reactions are sequentially 
performed. This approach has several advantages, firstly higher assay sensitivities are 
achieved because the molecules of interest do not have to be transported and thus they 
interact with less surface area, reducing the loss of target “molecules”. Second the 
purpose or function of the structure is completely determined by the fluid flown into it and 
its previous contents, thus by selecting the sequence of input fluids the multipurpose 
structure can be “programmed” to perform a variety of complex assays. In addition the 
simplicity of the multipurpose structure and its operation allows it to be easily multiplexed 
into an array that can perform a large number of simultaneous integrated assays.  
6.1.1 Characterisation of Basic Unit Operations 
 
To demonstrate the effectiveness of the novel design and operation the two basic unit 
operations (Figure 3.6 E); 1. Cell capture and 2. Fluid loading and diffusive mixing are 
characterized. Computational fluid dynamics was used to predict the effect of the main 
design parameters on the performance of the principal unit operations (see Section 
3.3.10). These unit operations are cell capture and fluid loading and mixing. Cell capture 
allows the loading and retention of cells or particles in the processing chamber, through 
the gravitational sedimentation and capture of particles that are denser than the 
medium. The particle trajectories were calculated by solving the force balance equation 
for each particle (see Section 2.3). 
 
The particle capture efficiency within the processing chamber trench was evaluated for 
different inlet velocities, trench geometries and particles sizes. From the calculations it 
(Figure 5.2A-C) can be seen that a 100 % particle capture efficiencies can be achieved 
as long as the operational range of the fluid inlet velocity is kept below 100µm/s and the 
ratio of the channel to trench depth (h1/h0) is over 5. As was shown by Manbachi et al. 
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2008 [2] once the particles reach the bottom of the processing chamber trench, they are 
shielded from shear stress, this is because the magnitude of the fluid velocity at the 
bottom of the trench is at least 3 orders of magnitude less (Figure 5.5) as compared to 
the top of the trench in chambers with a channel to trench depth (h1/h0) ratio over 5. This 
result also means that once cells or particles reach the bottom of the trench they are 
effectively captured. This was confirmed in experiments with 1.5-µm silica beads and 
input flow speeds of 20 µm/s close to 100% of the beads were captured within the 
chamber (see Figure 5.5, and movie SM2). Experiments with adherent cells (HeLa, 
MCF7) and non-adherent cells (plasma cells U266, macrophage J774) also 
demonstrated very high capture and retention efficiencies (see movie SM8). The number 
of loaded cells in each processing chamber can be controlled by the loading time (Figure 
5.6B-C) and the density of the cell suspension at the inlet. In addition, the successful 
capture and retention of bacterial cells (E. coli) at the bottom of the trench was also 
demonstrated, however; the capture efficiency of E. coli was low due to the small 
difference in density between bacterial cells and the aqueous medium (see Figure 5.7 
and movies SM3 and SM4).    
 
Species loading and mixing within the processing chamber and the trench geometries 
was predicted by calculating the transient convection and diffusion mass transport model 
(eq. 2.10) in a transient incompressible Navier-Stokes fluid velocity field (eq. 2.4) within 
the trench geometry.  
 
The calculations (Figure 5.2D-E) demonstrate that the average concentration of a 
species within the trench can be completely controlled by the fluid flow over the trench. 
The removal of the initial species by a new species is simply done by flowing the new 
species over the trench, and allowing for the new species to diffuse into the trench while 
the initial one diffuses out of the trench. This can be repeated in a cyclical manner to 
produce a sequential exposure of the cells in the trench to different species (Figure 
5.2D). If an intermediate mixture level is required within the trench such that a fraction of 
the mixture in the trench should correspond to the new species and the rest to the initial 
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contents then that result can be achieved by stopping the flow at a time ts < Tn (Tn is 
the time to complete species replacement within the trench, see Section 3.3.10) as 
shown in Figure 5.2E-F. Once the flow has been stopped the 2 species mix through 
diffusion and the concentration within the trench is homogenised (Figure 5.2E-F).  
 
Figure 5.2. Predicting the effect of the main design parameters on the performance of 
the basic unit operation using computational fluid dynamics. (A) Particle trajectories for 
different inlet velocities and trench geometries (B) Trench length and inlet velocity effect 
on the particle capture efficiency η (C) Trench depth and inlet velocity effect on the 
particle capture efficiency η (D) sequential loading (inlet velocity 10-4 m/s) of species CA 
(D ~ 10-10 m2/s) into a trench structure h1/h0=6.25, L/h0=2.5 with species CB. (E) Time 
lapse of the CA concentration within the trench during the creation of a 0.8CA : 0.2CB 
mixture, flow is stopped at Ts= 80s or at Tn=0.444. Within 40 s the CA concentration (D 
~ 10-10 m2/s) homogenizes and stabilizes within the trench (F) Creation of several 
mixture ratios of the initial species CB and the new added species CA in the trench 
structure, the mixture ratio is controlled by the flow stopping time TS which is less than 
the refreshment time Tn. 
 
 
Species form within the trench can diffuse out and into the surrounding channel but the 
reduced micron scaled dimensions if the channel delay that process, such that average 
the concentration within the trench can be kept constant within a ± 10% variation for 
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over 150 min (Figure 5.3) sufficient for most enzymatic reactions such as PCR or  
 
 
 
Figure 5.3.  Mixtures can be maintained within the trench for long periods of time 
without the need for active valves. If the flow is stopped at a time ts < Tn then a mixture 
is created and maintained as shown in the figure. For variation of ± 10% the mixture can 
be stable for over 150 min. Simulation parameters: diffusion coefficient D=5.9 x 10-9 m2/s 
geometry h1/h0 = 6.25, L/h0 = 2.5. For proteins or bigger bio-molecules, D is usually 2 
orders of magnitude smaller (D ~ 10-11 m2/s) so mixtures are more and last for longer 
times. 
 
 
 
 
Figure 5.4. By using a mineral oil layer reagent volumes as low as 50 nL can be loaded 
into the processing chamber. This reduces the reagents costs and allows the device to 
be used in applications where sample or reagent volumes are extremely limited, scale- 
bar: 9 mm .  
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Figure 5.5. (A-B) CFD simulation results of the flow velocity magnitudes in the 
processing chamber and trench. Cell capture is achieved due to the flow velocity 
magnitude in the trench being approximately 3 orders of magnitude lower the flow above 
it. So particles that enter the low flow velocity region are effectively captured. 
Experiments with 1 µm silica beads (C) demonstrate the capture efficiency of the 
structure. See support movie SM2 (D-E) Cancer (HeLa) cells are also efficiently 
captured in the processing chamber, scale-bar: 100 µm. 
 
 
NASBA [3]. This is a similar strategy to the one used by Du et al. 2009 [4] to maintain 
stable gradients within microfluidic channels for several hours. Experimental results with 
a fluorescent dye confirmed that when a new solution is flown into the processing 
chamber it gradually mixes with and finally replaces the previous contents of the 
chamber (Figure 5.8) and that the time to complete species replacement within the 
trench Tn is dependent on the flow velocity over the trench. 
 
Gravity driven fluid control is accomplished by inserting a standard pipette tip into a 
primed device inlet and then loading it with the input fluid (Figure 5.6A), the flow velocity 
is regulated by the height of the fluid column. By using standard 200 µL pipette tips, 
velocities of more than 600 µm/sec can be generated at the inlet of the processing 
chamber. The hydrostatic pressure head of small inlet volumes can be increased by 
stacking a second (immiscible and inert) liquid such as mineral oil on top. This allows 
volumes as low as 50 nL to be readily driven into each processing chamber (Figure 5.4). 
 116
This method makes the device ideal for applications where sample or reagent volumes 
are very scarce or expensive. 
 
 
Figure 5.6. Unit operations: (A) Gravity driven fluid control that depends on the height of 
the fluid column. The height of the fluid column can be regulated by controlling the 
amount of fluid inserted into the tip. (B-C) Cell capture is accomplished by allowing cells 
in the flow to sediment to the bottom of the central trench structure. Flow velocities at the 
bottom of the trench structure are 3 orders of magnitude lower than in the rest of the 
device allowing the cells to be effectively retained. Due to the high capture efficiency the 
number of loaded cells in the trenches can be controlled with the cell loading time.   
 
 
Figure 5.7. GFP E. Coli were captured with the processing chamber allowing bacterial 
cell based assays to also be done with the iCell array.  (A) Initially the device is loaded 
with the bacterial solution, (B) After which a washing solution is flown in to rinse out any 
non captured bacteria. Due to the low flow field at the bottom of the processing chamber 
trench, the bacteria present there will be effectively captured and not washed away. Due 
to the very low density of the E. Coli bacteria, the capture efficiency is much lower than 
that of denser particles or cells such as cancer cells.     
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6.1.2 Complex Integrated Assays 
 
The basic unit operations can be dynamically and seamlessly combined into sequences 
that perform more complex integrated assays. The key characteristic of the trench 
structure is the ability to efficiently capture cells through sedimentation and the mere 
diffusive loading, mixing and replacement of liquids through a controlled flow over the 
top of the trench. As shown in Figure 5.1 a wide range of cell-based assay can be 
performed in parallel on the same platform. Figure 5.1 illustrates the combination of 
individual operation units required for a cytotoxicity assay, real time gene expression 
analysis (NASBA) and immuno-fluorescent protein analysis. Priming of the chip, loading 
with the cell suspension and cell capture are common unit operations for all three 
assays. The user has now the option to grow the cells within the chip by continuously 
perfusing the cells with fresh medium or to perform molecular analysis assays directly on 
the captured cells. Cells can be stimulated with drugs and fixed, permeabilized or lysed 
for the consecutive analysis. In this study several assays were implemented on-chip 
including, a tmRNA based E. coli diagnostics assay, Paclitaxel cytotoxicity assay, gene 
expression analysis on mRNA level of the Estrogene receptor alpha (ESR1 - is 
associated with breast cancer) and the protein expression analysis of the ESR1 nuclear 
receptors. In order to further demonstrate the versatile potential of the chip, a drug 
treatment study for the down regulation of ESR1 nuclear protein was performed.     
 
The initial steps for on-chip experiments are often shared by a number of different cell-
based assays (Figure 5.1). The priming of the chip and cell capture is usually followed 
by a sequential combinations of unit operations such as cell culture, fluorescent staining 
and lysis (Figure 5.8). On-chip cell culture showed quick adoption of cells to the new 
microenvironment and exponential cell growth until reaching of confluence in three days. 
Cells were cultured under continuous perfusion with a constant feed of nutrients with 
fresh medium and constant removal of cell growth by-products with the out going feed.  
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Figure 5.8. Fluid loading and mixing unit operation is achieved due to the slow diffusion 
mixing of the input fluid with the previous contents of trench. (A) Experiments with 
fluorescent dye (DCF) mixing with water. (B) Dependence of the mixing speed on the 
input flow velocity. (C) Simulations demonstration the mixing of DCF with water within 
the trench. The fluid loading and mixing unit operation enables the execution of  some 
basic cell based assay procedures such as cell culture and staining (D) and cell lysis 
(E). 
 
Moreover, cells captured in the trench structure are protected from the shear stress of 
the flowing medium due to minimal velocities in the bottom of the trench. Trapped cells 
were exposed to CA staining and Propidium iodide showing cell viability after five days 
of cell culture (Figure 5.8D). Finally, fluorescently stained cells were lysed using a 
commercial buffer compatible with nucleic acid amplification for 30 min and the 
efficiency of the cell lysis was monitored in real time by fluorescent microscopy. Figure 
5.8E demonstrates the cell lysis process which initiates within five minutes and it is 
almost complete within less than ten minutes from the loading of the lysis reagent.  
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Figure 5.9. iCell array real time NASBA (A) End-time fluorescence within the processing 
chambers after the (B) real time NASBA E. coli diagnostic assay. This further 
demonstrates that rapid  and sensitive NASBA can be performed within the iCell array 
chip. (C-F) Oncogene: Estrogen Receptor Alpha (ESR1) integrated single-chip cell 
based assays. Multiplexed real time NASBA assays detects the expression of the ESR1 
gene in comparison to the house keeping gene PPIB in (C) HeLa and (D) MCF7 cells. 
As expected the ESR1 gene is highly expressed in the MCF7 cells. (E) This was further 
verified with a ESR1 nuclear receptor protein detection immuno-fluorescent assay.  
U266 (MM), 59M, MCF7 and HeLa cells on-chip, fixed, permeabilized and nuclear 
stained using Propidium iodide (PI) and anti-ESR1 (green) antibody. (F) MCF7 cells 
show specific nuclear staining for ESR1. All standard error bars are based on the eight 
replicates (n=8) in each processing module. 
 
 
Nucleic acid analysis based amplification of RNA and real time detection can be readily 
performed within the device. Real time NASBA is used for the nucleic acid detection on-
chip. Compared to other in-vitro amplification methods such polymerase chain reaction 
(PCR) [5], strand-displacement amplification (SDA) [6] or rolling-circle amplification 
(RCA) [7], NASBA has the unique characteristic that it can, in a single step, amplify RNA 
sequences. Furthermore NASBA has the unique ability to specifically amplify RNA in a 
background of DNA of comparable sequence [8], this reduces the requirements on 
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sample purification. Also since NASBA operates at 41 ºC, much lower than the 95 ºC 
required in PCR cycling, there are fewer problems with on-chip the sample drying or 
thermal displacement, eliminating the need for valves or other active components for 
containing the contents of the reaction chamber. It also reduces the thermal design 
requirements of the chip and makes the chip operation simpler.  
 
Here NASBA is demonstrated (Figure 5.9) by performing an on-chip E. coli diagnostic 
assay. Based on custom designed RiboSEQ targeting primers [9] and molecular 
beacons the device was able to detect down to 10 E. Coli cells in 100 µL within 7 
minutes (Figure 5.9B), giving a sensitivity of approximately a single target copy. Note 
that each E. coli contains approximately 500-1,000 copies [10] of the tmRNA RiboSEQ 
target fragments resulting in approximately a single target copy within a 10 nL volume. 
tm-RNA also has a relatively high stability compared to mRNA which also increases the 
detection robustness. This sensitivity is also reinforced by the larger depth of trench 
geometry of the processing chamber that insures that more fluorescent signal is 
collected in a single exposure. This is also clearly evident in Figure 5.8A-B where at 
constant fluorophore concentration and excitation, the intensity of the fluorescent signal 
collected from the trench area is 8 fold higher then one from the inlet channel.  
 
Next, NASBA is performed on eukaryotic cells captured in the iCell array. Since 
estrogen receptor alpha (ESR1) is a major oncogene in breast cancer [11], ESR1 
positive MCF7 breast  cancer  cells were used to  demonstrate multiplexed, real time 
NASBA-based  gene  expression  analysis. Furthermore this analysis was 
complemented with an ESR1 protein detection based on immuno-fluorescent staining. 
With primers and molecular beacons specific to ESR1 and to the house keeping gene 
PPIB [12] the device is capable of performing an integrated real time NASBA protocol 
(Figure 5.9C-D) from as few as ten cells. Due to the versatility of the iCell array an 
immuno-staining assay on-chip was used to detect the expression of ESR1 protein. 
Since gene level expression of ESR1 was shown in MCF7 cells using NASBA and its 
absence in HeLa cells, the same model cells were used for immunostaining. ESR1 
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protein is known to be localized in the nucleus of MCF7 cells [13] and absent in HeLa 
cells [14]. Additionally other cell lines were used; the ovarian cancer cell line 59M and 
non-adherent plasma cells U-266 (MM) to investigate the protein analysis. The cells 
were captured, fixed, permeabilized and immunostained on the chip (Figure 5.9E-F). 
The anti-ESR1 antibody staining showed a specific nuclear staining in MCF7 cells and 
much lower staining signals in HeLa, 59M and U-266 cells. 
 
These can be further combined into a complete drug study experimental protocols, this 
was demonstrated (Figure 5.10) with a cytotoxicity analysis of the anti-cancer drug 
Paclitaxel [15] on HeLa cells and a study of the down regulation effects of the As2O3 
drug on ESR1 in breast cancer cells MCF7.  
 
Paclitaxel is a well know anti-cancer agent that reduces the growth and proliferation of 
cancer cells. To perform the dynamic cytotoxicity experiments 64 processing chambers 
were loaded with approximately 50 HeLa cells and cultured for one day after which the 
cells were stimulated with eight different concentrations of Paclitaxel raging from 0 µM 
(control) up to 100 µM for 48 hours. Cell viability was quantified through Propidium 
iodide and Calcine AM fluorescent staining of all the cells. As expected the fluorescent 
imaging revealed (Figure 5.10A-B) that as the drug concentration is increased and so 
does the number of dead cells in relation to the number of live cells.  
 
The effects As2O3 on ESR1 expression were studied by loading 128 processing 
chambers with ESR1 positive MCF7 cells and as a negative control ESR1 negative 
HeLa cells. The MCF7 cells were stimulated for 48 hrs with seven different 
concentrations of As2O3 and the ESR1 protein quantified with nuclear immuno-
fluorescent staining. As in previous reports [16] the results show (Figure 5.10C) that 
As2O3 has a strong effect in down-regulating the expression of ESR1 in MCF7 cells.  
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Figure 5.10. Complete drug study experimental protocol execution on the iCell array. (A) 
HeLa based cytotoxicity assay validating the effect of Paclitaxel, a well know anti-cancer 
agent that (B) reduces the growth and proliferation of cancer cells. (C) Study of the down 
regulation effects of the As2O3 drug on ESR1 in breast cancer cells MCF7. In a fully 
integrated on-chip assay the effects of arsenite on the protein expression of ESR1 in 
MCF7 cells were studied by loading 128 processing chambers with MCF7 and HeLa 
cells and stimulating the cells with several concentrations of As2O3 over a period of 72 
hrs, after which the protein expression was analysed on-chip with immuno-fluorescent 
nuclear staining and detection. All standard error bars are based on the eight replicates 
(n=8) in each processing module. 
 
 
6.2 Discussion  
 
The iCell array is compatible with standard existing laboratory infrastructure. The inlet 
distribution is the same as that of standard 96 well plate so cells and reagents can be 
loaded using multichannel pipettes and/or pipetting robots (Figure 5.11). Additionally in 
contrast to standard microfluidic devices that use syringe pumps, reagent replacement 
or refilling is done in a simple and bubble free manner; this way cells are loaded 
efficiently and with very low shear stress into the device. The trench structure captures 
and isolates cells from the direct flow which also enables the capturing and processing 
of bacterial cells (Figure 5.7 and movies SM3, SM4). Furthermore the iCell array 
integrates flow control and gravity driven pumping which makes it independent from 
external pumps or other macroscale active components and allows it to be easily 
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inserted and used within incubation or environment control chambers and standard 
fluorescent microscope systems or even some plate readers. In essence the iCell array 
is a nanolitre processing multi-chamber plate that can perform dynamic flow assays with 
high sensitivity, high level of integration (experiment to answer), and spatial multiplexing 
without the need for cumbersome, custom made and expensive external active control 
components such a pumps, pressure sources, solenoid valves, etc. The fabrication 
process is a simple two layer soft photolithography that does not require precise 
alignment of multiple layers since only the 1.3 mm inlets have to be aligned to the 
fluidics layer allowing a large tolerance. Furthermore due to fluidic resistance all the 
processing modules are fluidically independent so in applications that do not require the 
use of the complete 512 processing chambers the user can load a subset of modules 
without having to seal the remaining inlets. This simplifies the iCell array operation 
protocols. 
 
 
 
Figure 5.11. With on-chip gravity driven flow control, iCell array is flexible and can be 
easily integrated into existing infrastructure and workflows such as robotic pipetting 
systems (A), incubators (B), and fluorescent microscope systems (C). 
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6.3 Conclusions  
 
This work has demonstrated a novel microfluidic platform, the iCell array, that can 
perform completely integrated complex cell based assays with real time NASBA based 
nucleic acid amplification and protein expression detection. The technology can 
combine, in an array format, unit operations such as particle or cell capture, filtering, 
reagent loading, mixing and controlling in a simple and configurable way. This permits 
the parallel and versatile on-chip integration of complex procedures such as cell culture, 
cell stimulation, cell lysis, cell fixing, protein immunoassays, bright field and fluorescent 
microscopic monitoring, and real time detection of nucleic acid amplification. High assay 
sensitivity is achieved by trapping and retaining cells or biopolymers of interest in the 
same space where reactions are sequentially performed. The iCell array system does 
not require any off chip steps providing a true experiment to answer capability. With 
onboard gravity driven flow control the device is simple and economical to operate, it 
uses less reagent volumes, and it does not require external macro-scale power sources. 
This enables the iCell array to be directly used with existing laboratory infrastructure 
such a multichannel pipettes and/or robotic fluid handling systems, incubation or 
environmental control chambers and microscope systems. In its current design the iCell 
array can process up to 512 10 nL reactions in a single chip and up to 64 different 
integrated assays can be done simultaneously. To be best of my knowledge this is the 
first demonstration of a versatile fully integrated microfluidic array platform for dynamic 
cell studies which can be universally and economically used in any biological laboratory. 
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6.5 Supporting Movies 
 
 
SM1. iCell array processing module priming based on the degassing method.  
Movie file: SM1.priming.bubble.removal.avi  
SM2. iCell array 1 micro particle capture with very high efficiency (3 movies). 
Movie file: SM2a.1um.silica.bead.capture.avi   
Movie file: SM2b.1um.silica.bead.capture.avi   
Movie file: SM2c.1um.silica.bead.capture.avi     
SM3. iCell array GFP E. Coli loading. 
Movie file: SM3.GFP.EColi.loading.avi  
SM4. iCell array captured GFP E. Coli with washing flow above them.   
Movie file: SM4.Captured.GFP.EColi.during.washing.step.avi  
SM5. Lysis movie. 
Movie file: SM5.Lysis.HeLa.cells.avi 
SM6. Real Time NASBA movies showing the increase in fluorescence over time. 
Movie file: SM6.Real-time.NASBA.avi 
SM7. Mixing simulation.  
Movie file: SM7.Mixing.Simulation.mpg 
SM8. Cell loading movie of plasma cells U266 with an inlet velocity of ~300 µm/sec.  
Movie file: SM8.Cell.loading.movie.avi   
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Chapter 7: Conclusions and Prospects 
 
 
With the successful demonstration of the iCell array micro-device that can perform cell 
stimulation followed by protein and genetic analysis on a single substrate a variety of 
possible applications become apparent. Here several improved schemes for future 
generations of micro-devices are presented. 
7.1 Future Improvements  
 
One of the important advantages of microfluidic systems in cell based assays is that by 
controlling flow over the cells, precise perturbations of the cellular environment in time 
and space can be accomplished. The perturbations can be done on adherent and non 
adherent cells in microfluidic devices. The key to this control ability lies in the diffusive 
mixing properties of laminar flow created by microfluidics. With laminar flow complex 
concentration gradients not achievable on a macro-scale can be realized. These 
gradients allow several conditions to be probed simultaneously while also mirroring 
conditions found in vivo. Furthermore gradient generation permits many growth 
conditions to be analyzed in a combinatorial fashion. Diffusion within microfluidic devices 
is often too slow. Although slow diffusion poses a complication when mixing is desired, 
slow diffusive mixing creates opportunities for varying the liquid-phase environment over 
distances comparable to the size of cells. This has enabled demonstrations such as the 
migration of organelles from one side of a cell to the other when a single endothelial cell 
was subject to a gradient that varied across the cell. Since gradients are such an 
important aspect of microfluidic systems an approach is proposed to incorporate any 
gradient generator to the system described in the previous section. This approach can 
also be used to incorporate additional functionality such as reagent distribution and 
metering mechanisms.  
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Figure 6.1. Modular approach for implementing further microfluidic functionality without 
sacrificing versatility. (A) Versatility is maintained by having an array of modules, and 
each module can implement a different fluidic function; here is a conceptual design of 4 
basic modules, although further modules can be developed. The central reaction unit is 
where the cell a captured and processed. (B) For use the modules can be mounted and 
later disassembled (when reversible bonding is used). (C) During operation gravity 
driven flow can be harnessed for perfusion and loading the same way it is currently 
done.  
 
 
The approach is based on a modular concept. Each module is a fluidic layer and the 
modules connect to each other by stacking. The modules are mounted by connecting 
their inlets and outlets, thus simplifying the alignment requirements. Figure 6.1 
demonstrates this.    
 
The reasons in favour of perusing this approach are: 
1. The ability of PDMS to reversibly bond to other surfaces made from materials 
such as glass or polymer. 
2. No high pressures are required during the operation of the mounted modules. 
3. Versatility is determined by the upper modules so any new application would 
just require a change of the upper fluidic module. 
4. The upper fluidic module also allows the reaction trenches to be closer to each 
other, thus increasing the reaction density in the central reaction unit (Figure 
6.1A).    
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A further advantage of this approach is that more complex experimental protocols can 
be implemented in a versatile manner by just sequentially combining the use of several 
different upper modules and maintaining the lower central reaction unit. This is 
conceptually shown in Figure 6.2 depending on the required fluidic operation the upper 
module is changed. 
 
 
Figure 6.2. Complex experimental protocols can be implemented in a versatile manner 
by using a sequence of upper fluidic modules and maintaining the same central reaction 
unit. 
 
 
By adding thin film tin-doped indium oxide heaters on the base of the cell processing 
module cell culture and NASBA thermal control can also be miniaturized.  
 
7.2 Further Applications  
 
One of the unique advantages of the trench based cell capture is that the device can 
also function with non-adherent cells such as E.Coli and Macrophages. By loading two 
or more cell types into a single trench the cell interaction can be studied. As a 
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demonstration of that the figure (Figure 6.3) below demonstrates the result of combining 
genetically modified fluorescent E. Coli with J774 macrophages. The time lapse images 
show the activation and phagocytosis of the E.Coli bacteria by the macrophages. As 
time progresses the macrophages scan the surface and phagocytose most of the 
bacteria, leaving behind a cleaner surface. In this application the device could be used 
to perform quantitative measurements of the process, for example the cell trajectories 
can be tracked and statistically analyzed, furthermore the ingestion and digestion 
parameters can be studied and quantified. The modulation of drugs or other stimulation 
agents on the response of these processes can also be studied because soluble factors 
can be dynamically perfused during the interaction of the two non-adherent cells.  
 
 
Figure 6.3. Active J774 macrophages captured in the trench are seen taking up green 
fluorescence protein (GFP) containing E.Coli cells in a cooperative manner. The 
macrophage fluorescence increases as they engulf more E. Coli. The total fluorescence 
is reduced as the macrophages digest the E. Coli cells with GFP. Scale bars represent 
50 µm.   
 
 
The trench structure’s ability for real time perfusion of soluble factors and bright field and 
epifluorescent monitoring combined with the micro-scales of the miniaturized device can 
also enable a novel application that has not been reproduced in the macro-scale. The 
real time monitoring of cell surface protein expression as it occurs during cell stimulation. 
The principle that enables this measurement and the initial experimental data are shown 
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in Figure 6.4. The real time protein expression measurement was achieved by 
maintaining a very low concentration of fluorescently labelled anti-bodies in the perfusion 
medium. The fluorescent anti-body in this case was specific to the CD86 costimulatory 
molecule. During an antigen-dependent inflammatory response macrophage cells are 
activated and over express costimulatory molecules such as CD80, CD86 and CD40 on 
their surface which helps induce an effective T cell response. This is one of the key 
mechanisms and outcomes of activated macrophages that makes them behave as 
antigen presenting cells (APCs) and activates the adaptive immune system. During the 
real time monitoring of surface protein expression J774 macrophages were activated 
with LPS (200 ng/ml) in the positive control case, while in the negative control no LPS 
was present in the culture medium. As the stimulated macrophages began to express 
the CD86 proteins on the cell surface, the fluorescent CD86 anti-bodies generated a 
fluorescent signal from the cell surface. As the free solution antibodies are being 
consumed and bound on the cell surface, new ones replace them through the 
continuous perfusion. This maintains a constant supply of in solution antibodies and 
enables the real time monitoring of the CD86 protein expression on the surface of the 
macrophage cells. Furthermore the micro-scale dimensions of the device keep the 
background fluorescence generated by the in solution antibody to a minimum, lowering 
the LOD to physiologically relevant levels. This measurement technique can be further 
enhanced by simultaneously using several anti-bodies with different fluorophore labels 
to generate simultaneous real time multiple surface protein readout with single cell 
resolution. This novel measurement can be very relevant to fundamental studies in 
systems and cell biology research and it also has the potential to be a very relevant 
diagnostic tool. 
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Figure 6.4. Real time monitoring of cell surface protein expression. (A) Measurement 
principle as demonstrated by CD86 protein measured in real time on the surface of J774 
macrophage cells during an LPS stimulation. (B) Time lapse images of J774 cell being 
stimulated with LPS (200 ng/ml) and real time kinetic quantification of single cell CD86 
surface concentration of stimulated and non-stimulated cells.  
 
 
7.3 Summary of Results 
  
Fundamental components and mechanisms necessary for highly integrated and parallel 
cell-based bio-analytical micro-devices were developed and demonstrated. Furthermore 
the complexity of the components and mechanisms was kept to a minimum making 
them highly up-scalable and economical to use.  
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Critical issues were addressed in this work by first demonstrating an integrated 
microfluidic tmRNA purification and real time nucleic-acid-sequence-based-amplification 
(NASBA) device.  The integrated device produced a pathogen-specific response in less 
than 3 min from the chip-purified RNA. Further enhancements produced a novel 
integrated NASBA array and then a more versatile iCell array. 
   
The versatility of the iCell array is based on the novel combination of hydrodynamics 
and cell sedimentation within micro-trench structures and gravity driven sequential 
perfusion and diffusion mechanisms. This led to the development of a novel microfluidic 
technology that can completely integrate cell based assays with bio-analytical read-out. 
The highly scalable iCell array mechanisms enable the configurable on-chip integration 
of conventional procedures such as adherent and non-adherent cell-culture, cell-
stimulation, cell-lysis, cell-fixing, protein-immunoassays, bright field and fluorescent 
microscopic monitoring, and real time detection of nucleic acid amplification. 
Furthermore the micro-scale characteristics of the technology enabled unique and novel 
stimulations, operation and protein read-out procedures that can not be effectively 
implemented in the macro-scale. 
 
With on-board gravity driven flow control the device is simple and economical to operate 
with dilute samples (down to 5 cells per reaction), low reagent volumes (50 nL per 
reaction), highly efficient cell capture (approximately 100% capture rates) and single cell 
protein and gene expression sensitivity. The key results from this work demonstrate a 
novel technology for versatile, fully integrated microfluidic array platforms.  
 
By multiplexing this integrated functionality, the device can be used from routine 
applications in a biology laboratory to high content screenings. Thus this technology can 
be instrumental in helping fulfil the promise of microfluidics to change significantly the 
way modern biology is performed. 
